






    
   








     
    
     





Crystallography and Kinetic Study of
Quinol-Dependent Nitric Oxide
Reductase from Neisseria Meningitidis
Muhamad Arif bin Mohamad Jamali
Department of Life Science







   
    
    
   
    
   
   
   
   
  
                     
   
   
   
   
   
   
   
   
 
            
   
Table of Contents
Table of Contents................................................................................................................. I
List of Publication and Internation Conference.................................................................IV
Abbreviation ........................................................................................................................1
Abstract................................................................................................................................2
Chapter 1: Introduction .......................................................................................................2
1.1 Nitrogen Denitrification ....................................................................................2
1.2 Bacterial Denitrification System .......................................................................3
1.1 Active Site Structure of NOR............................................................................7
1.1 Objective In This Study.....................................................................................9
Chapter 2: Crystal Structure of Zinc Bound Nitric Oxide Reductase from N. Meningitidis
by X-ray Crystallography ................................................................................11
2.1 Introduction .....................................................................................................11
2.2 Materials and Methods ....................................................................................13
2.2.1 Purification of NmqNOR..................................................................13
2.2.2 UV-visible spectra measurement......................................................13
2.2.3 Protein crystallization, data collection and structure determination.14
2.3 Results and Discussion ....................................................................................15
2.3.1 Purification and oligomerization of NmqNOR.................................15
2.3.2 Crystal structure of NmqNOR ..........................................................17






                     
   
   
   
   
   
   
   
   
 
            
   
   
   
  
   
   
   
   
   
   
  
             
   
Chapter 3: Native Structure of quinol-dependent Nitric Oxide Reductase from
N. Meningitidis by Cryo-Electron Microscope.................................................27
3.1 Introduction .....................................................................................................27
3.2 Materials and Methods ....................................................................................29
3.2.1 NmqNOR-BRIL Constructure and Purification ...............................30
3.2.2 Cryo-EM Sample Vitrification and Data Acquisition ......................30
3.2.3 Image Processing of Cryo-EM Movies ............................................31
3.2.4 Model Building and Refinement of Cryo-EM Structures ................32
3.3 Result and Discussion......................................................................................34
3.3.1 Native Structure of NmqNOR by Cryo-EM .....................................34
3.3.2 Structural Comparison of Crystallographic Zinc-bound and 
Cryo-EM of NmqNOR .....................................................................47
3.3.3 Active Site Structure of NmqNORs..................................................50
3.3.4 Putative Proton Transfer Water Channel..........................................50
3.4 Conclusion .......................................................................................................53
Chapter 4: Steady State Kinetic of NmqNOR with Electron Donor Analogue Inhibitors 54
4.1 Introduction .....................................................................................................54
4.2 Materials and Methods ....................................................................................57
4.2.1 Purification of NmqNOR..................................................................57
4.2.2 UV-visible spectra measurement......................................................57
4.2.1 Measurement of NO consumption of NmqNOR ..............................57
4.3 Results and Discussion ....................................................................................60
4.3.1 NO reduction by detergent solubilized NmqNOR with different
electron donors ................................................................................60




             
 
             
   
   
   
   
   
    
   
   
    
   
   
   
   
   









4.3.3 Electron Transfer Inhibition of NmqNOR by quinol-based
inhibitor ...........................................................................................66
4.3.3 Comparison of Quinol Binding and Electron Transfer between 
qNOR and Cyt. bo3 .........................................................................72
4.4 Conclusion .......................................................................................................73
Chapter 5: Structure of NmqNOR with Inhibitor Complex by Cryo-EM .........................74
5.1 Introduction .....................................................................................................74
5.2 Materials and Methods ....................................................................................75
5.2.1 NmqNOR-HQNO purification..........................................................75
5.2.2 Cyo-EM Sample Vitrification and Data Acquisition .......................75
5.2.3 Image Processing of Cryo-EM movies.............................................75
5.3 Results and Discussion ....................................................................................80
5.3.1 HQNO binding position in NmqNOR revealed by Cryo-EM...........80
5.3.2 Structural Difference of Q-site between NmNOR and GsqNOR .....83
5.3 Conclusion .......................................................................................................85
Chapter 6: General Conclusion and Future Improvement.................................................86
6.1 General Conclusion .........................................................................................86








         
 
     
      




       
  
      
     
 




       
 
 
        
 
  
       
        
    
 
List of Publication
Part of this thesis have been published in the following paper
Chapter 2 and 3
The active form of quinol-dependent nitric oxide reductase from Neisseria meningitidis is a 
dimer.
Muhamad Arif Mohamad Jamali, Chai C. Gopalasingam, Rachel M. Johnson, Takehiko 
Tosha, Kazumasa Muramoto, Stephen P. Muench, Svetlana V. Antonyuk, Yoshitsugu 
Shiro and Samar S. Hasnain
Part of this thesis will be used as the manuscript for the following paper
Chapter 4 and 5
Structure and kinetic of quinol-dependent nitric oxide reductase from Neisseria 
meningitidis with presence of inhibitor.
Muhamad Arif Mohamad Jamali, Chai C. Gopalasingam, Hideki Shigematsu, Takehiko 
Tosha, Kazumasa Muramoto, and Yoshitsugu Shiro.
List of International Presentation
Steady state kinetic of quinol oxidation by nitric oxide reductase form Neisseria Meningitidis.
9th Asian Biological Inorganic Chemistry (AsBIC) Conference (2018, Singapore)
Muhamad Arif Mohamad Jamali, Takehiko Tosha, Kazumasa Muramoto, and Yoshitsugu
Shiro.
Crystallographic and cryo-EM structures of quinol-dependent Nitric Oxide Reductases from
Neisseria meninigtidis
International Symposium on Diffraction Structure Biology (2019, Japan)
Muhamad Arif Mohamad Jamali, Chai C. Gopalasingam, Rachel M. Johnson, Takehiko 
Tosha, Kazumasa Muramoto, Stephen P. Muench, Svetlana V. Antonyuk, Yoshitsugu








   
    
     
    
   
   
  
     
   
   
   
    
   
   
   
   
   







NOR nitric oxide reductase
CcO cytochrome c oxidase
DDM Dodecyl β-D-maltoside
DTM Decyl−β−D-Thiomaltopyranoside
HCO heme copper oxidase
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid




cNOR cytochrome c depended NOR













        
         
        
       
       
     
     
          
        
      
    
  
     
     
        
     
    
        












Quinol dependent Nitric Oxide Reductases (qNOR) are key enzymes of the
denitrification pathway, converting the free radical nitric oxide to the potent greenhouse gas
nitrous oxide. Structural details of the catalytic site arrangement and putative proton transfer 
channel of NmqNOR remained elusive up till now. Reported are a zinc bound (proton channel
inhibitor) X-ray crystallographic structure and a native cryo-EM derived structure of active
NmqNOR at 3.2 and 3.1 Å, respectively. Zinc was bound at potential ‘entry’ and ‘terminal’ 
points of the putative proton transfer channel, with E494 involved in zinc ligation near the
active site. The spatial location of the zinc binding sites is comparable with cytochrome c
oxidase (CcO) inhibitory cadmium binding site at the analogous proton transfer K-channel
entry point. Comparisons between FeB coordination in NORs are discussed, alongside the
seemingly conserved metal inhibition profiles of proton channels amongst qNOR and 
evolutionarily related oxygen reducing CcO’s. Other than that, in qNOR, the electron is
supplied by UQH2. However, neither structural nor functional studies of electron transfer from
UQH2 to qNOR has been studied. Our results showed that purified qNOR oxidized ubiquinol
coenzyme (UQH2) and menadiol (MDH2), a soluble analog molecule of UQH2. Our
measurement showed that HQNO noncompetitively inhibited both UQH2 and MDH2 oxidation 
activity, while benzoquinone (BQ) competitively inhibited both UQH2 and MDH2. Elucidation 
of NmqNOR-HQNO complex at 3.1 Å by cryo-EM also shows how HQNO noncompetitively 
binds in q-site of NmqNOR, providing future insight into how inhibitor binds into the electron 










         
      
      
        
       
       
      
   
      
        
       
       
        
       















Nitrogen is a vital component for all life. Important parts of many cells, genetic
materials (DNA and RNA) and amino acids (which make up proteins) are made up of nitrogen 
atoms. Approximately 80% of the earth’s biosphere consists of dinitrogen (N2), which is one
of the most chemically inert molecules due to its triple bond character with 946 kJ mol-1 bond 
energy. Thus, it is important for nitrogen to be regulated in the atmosphere to maintain the
balance of our life. Nitrogen cycle describes how nitrogen is regulated in the atmosphere and 
ecosystem. There are five main processes involved in this cycle, namely Nitrogen Fixation, 
Nitrification, Assimilation, Ammonification and Denitrification, as shown in Figure 1.1 
(Canfield, Glazer and Falkowski, 2010). The focus of this study is on the denitrification process
which involves the removal of excess nitrate, NO-3, in the environment by sequential reduction 
of the terminal electron-acceptor nitrate to nitrogen gas (W G Zumft, 1997). In this process, 
the four main components in bacteria as shown in Figure 1.2, namely Nitrate Reductase (NR), 
Nitrite Reductase (NiR), Nitric Oxide Reductase (NOR) and Nitrous Oxide Reductase (N2OR) 
convert NO-3 into N2 gas. The process can be summarized by the following equation: 2NO3- + 















          
     
   
        




          
            
      
         
        
       
      
       
          
             
          
       
  





















Assimilatory and Dissimilatory NO -
NO
Figure 1.1. Overall process of Nitrogen cycle. The five main processes in the nitrogen cycle
are shown. Red arrows show Nitrification process, Blue for Denitrification process, purple
shows Nitrogen Fixation process and grey for Assimilatory and Dissimilatory NO3
- reduction. 
Ammonia (NH3) can combine with NO2- fromDenitrification to formN2H4 in theANAMMOX
process which is labelled in green.
1.2 Bacteria Denitrification System
Conversion of nitrate to nitrite (NO3- + 2H+ + 2e- => NO2- + H2O) involves the enzyme of NR. 
This membrane bound metal enzyme has a heme as the active site that consists of 5 Fe-S 
clusters and catalytic domain as shown in Figure 1.2 (Bertero et al., 2003; Coelho and Romão, 
2015). The process is electrogenic where an electron from menaquinol is transported to the
catalytic domain before being transferred to heme active site, while proton uptakes from the
cytoplasm are transported towards the periplasmic region to generate water molecules. The
subsequent process in bacterial denitrification is nitrite reduction by either homotrimeric
copper containing NiR (NirK) or homodimeric heme containing NiR (NirS) (Maia and Moura, 
2014). This process involves the reduction of nitrite with single electron to form the toxic free
radical nitric oxide (NO2-+ e-+ 2H+ => NO + H2O), as shown in Figure 1.2 . The toxic NO gas
emitted from this process is reduced in the membrane-integral NOR (2NO + 2e- + 2H+ => N2O 
+ H2O) (Fig. 1.2). There are three types of respiratory bacterial NOR identified as cytochrome
c-dependent NOR (cNOR), di-copper NOR (CuANOR) and quinol-dependent NOR (qNOR) 
(Hendriks et al., 2000; T. Hino et al., 2010; Matsumoto et al., 2012; Al-Attar and de Vries, 
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2015). They are classified based on their electron donor and subunit composition. As illustrated  
in Figure 1.2, N2O gas produced by NOR is reduced back to dinitrogen gas in the final step of 
bacterial denitrification by N2OR with the following equation (N2O + 2e- + 2H+ => N2 + H2O).
Figure 1.2. Main component of Denitrification system in bacteria. Nitrate from the bacterial
environment are reduced into dinitrogen by four main components in bacteria Denitrification 
system, namely NR, NiR, NOR, and N2OR.
This thesis presents an in-depth study of a bacterial intermembrane NOR enzyme. 
Bacterial NOR is a metal enzyme that consists of a metal active site and belongs to the heme
copper oxidase (HCOs) superfamily (Sousa et al., 2012). The main composition of this
superfamily is respiratory enzyme Cytochrome c Oxidase (CcO) which performs the main 
function in the final stage of redox coupling in the electron transfer chain. Cco catalyzes 4 
electron reductions of oxygen molecules to water molecules (O2 + 4H+ + 4e- = 2H2O)
(Tsukihara et al., 1996; Ohnishi et al., 2010). The process of oxygen reduction occurs in the
active site in CcO that consists of heme and non-heme copper (CuB) as shown in Figure 1.3 
(A). NOR has a similar active site that consists of heme and CuB in NOR is replaced by the


















           
     
          
          
    
           
           
        
          
           
 
 
          
       
       
       
        
      
         
        



























Figure 1.3. Recent structure of CcO and NOR. (A) shows the recent crsytal structure of CcO
from bovine (PDB:6JYF), electron (black dash line) donated by cytochrome c enter via CuA 
(orange sphere) towards the active site that contains heme a3 and CuB(Shinzawa-Itoh et al., 
2019). Catalytic protons from the cytoplasm enter towards active site via two pathways
designated as K-pathway (orange dashline) and D-pathway (purple dashline), and protons
move towards the intermembrane space in the mitochondria from active site as shown in red 
dashline. (B) shows the latest cryo em strucuture (PDB: 6L3H) of qNOR where it has a putative
proton pathway, K-pathway analogue, from the crytoplasm towards the active site and red dash 
line shows the predicted direction of proton from the active site towards the periplasm. In 
qNOR, the electron was donated by the quinol towards the active site via the quinol binding 
pocket.
There are 3 main subgroups of NOR with one of the most intensively studied over the
past few years being cNOR, the other two are qNOR and CuANOR. In 2010, a research group 
from Biometal science laboratory (RIKEN, Japan) solved the first crystal structure of cNOR 
using NOR from Pseudomonas aeruginosa (T. Hino et al., 2010). This structure consists of 
two subunits of NorB and NorC. NorB is made up of twelve transmembrane helices (TM) and 
contains low-spin heme b, high-spin heme b3 and non-heme FeB. The main composition of 
NorC is a globular domain containng heme c that acts as the electron entry site, as shown in 
Figure 1.4(A) (Hendriks et al., 2000). CuANOR consists of three main subunits and has a close
evolutionary trait with CcO due to the smallest subunit having similar homology with that of
5
  
        
           
       
       
          
         
        
        














          
   
     
















    
   
CcO. The main subunit has similar traits with the cNOR which contains two heme groups and 
a non-heme FeB whereas the smallest subunit containing di-copper cluster acts as the entry site
for the electron(Al-Attar and de Vries, 2015). This study of the CuANOR was based on the
homology model by Al-Attar and de Vries (2015) (Fig 1.4 (B)). The third NOR, which is the
subject of this study is quinol-dependent NOR. qNOR is a single subunit NOR that contains
14 transmembrane helices harbouring two heme groups and a non-heme FeB (Hendriks et al., 
2000). The first crystal structure of qNOR, published by Matsumoto et al., 2012, was isolated 
from Geobacillus stearothermophilus (GsqNOR). However, the non-heme FeB was accidently 








Heme b Heme b 
A B C
Figure 1.4. Overal structure of NOR. (A) shows the first crystal structure of cNOR from P. 
aeruginosa. NorB was coloured in green and subunit NorC was coloured in cyan 
(PDB:3O0R)(Tomoya Hino et al., 2010). B) Homology model of CuANOR by Al-Attar and de
Vries (2015). C) shows a single subunit qNOR from G. stearothermophilus (PDB:
3AYF)(Matsumoto et al., 2012).
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qNOR is a class of NOR found in bacteria with a full denitrification system. Several
examples of qNOR in denitrifying bacteria such as G. stearothermophilus and Achromobacter
xylosoxidans (previously called Alcaligenes xylosoxidans), are utilized for reduction of NO as
a part of denitrification (Verbaendert et al., 2011; Jakobsen et al., 2013). Besides denitrifying
bacteria, qNOR is also present in the non-denitrifying pahtogenic bacteria, which lack the full
denitrification apparatus, as in Neisseria meningitidis (Barth, Isabella and Clark, 2009). N. 
meningitidis is the bacteria that causes meningitis and fully utilizes qNOR to survive from
macrophage; when qNORis knockedout from the cell, N. meningitidis shows depleted survival
rate in the nasopharyngeal tissue (Stevanin, James W B Moir and Read, 2005). A human 
macrophage can produce NO from arginine by inducible NO synthase (iNOS) as an immune
system to kill invading bacteria. Thus N. meningitidis has a prolonged survival rate in the
human tissue as it converts the toxic NO into less harmful N2O by qNOR (NmqNOR) (Nathan 
and Shiloh, 2000; Muna F. Anjum et al., 2002; Stevanin, James W B Moir and Read, 2005). 
In view of this situation, an in-depth investigation on the structure and function of qNOR is
crucial as a mean to explore the possibilities of development of anti microbial drugs among the
phatogenic bacteria that uses qNOR as a tool for antimicrobial resistance. 
1.3 Active site structure of NOR
Structural studies of NOR, as highlighted in Section 1.2, are crucial to understand the
mechanism of NO reduction in NOR. This reduction reaction occurs in the catalytic active site
of NOR. As of June 2020, five structures of NOR have been published, namely PacNOR, 
GsqNOR, RscNOR, AxqNOR, and NmqNOR (T. Hino et al., 2010; Matsumoto et al., 2012;
Crow et al., 2016; Gopalasingam et al., 2019; Jamali et al., 2020). The structures of published 
PacNOR and GsqNOR were obtained using X-ray crystallography while that of AxqNOR was
achieved using Cryo-Electron Microscope (cryo-EM). As shown in Figure 1.5(D), the
PacNOR, FeB is ligated by 4 ligands, 3 histidine residues and 1 glutamate residue. GsqNOR 
and AxqNOR have similar active site arrangements with FeB(AxqNOR) and ZnB (GsqNOR) are
ligated by 3 histidine residues only, as shown in Figures 1.5 (A) and (B). This active site 
















       
       
          















































Figure 1.5. Active site structure of NOR. (A) Active site of AxqNOR elucidated by cryo-EM 
method, active site was ligated by only 3 Histidine residues. (B) Active site structure of 
GsqNOR, grey ball indicated that FeB was replaced by the Zinc atom and the enzyme was
predicted as non-active NOR. (C) First bacterial membrane NOR from P. A aeruginosa
eluciated by Xray Crystallography method shows active site was ligated by 4 ligands.
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1.4 Objective of this study
To better understand how qNOR works, it is important to comprehend the active
structure and function of NmqNOR. Recently published work in NmqNOR showed this enzyme
was an electrogenic enzyme by a Respiratory Control Rate (RCR) experiment with the crystal
structure at 4.5 Å (Gonska et al., 2018). This energy conservation property of NmqNOR makes
it unique compared with the most studied cNOR, which is a non-electrogenic enzyme (T. Hino 
et al., 2010; Hino et al., 2012; Salomonsson et al., 2012; Terasaka et al., 2014). However, it
shows the same evolutionary property with CuANOR, which is closer to CcO (Al-Attar and de
Vries, 2015). The first objective of this study is to obtain a high-resolution structure of 
NmqNOR that provides a clear picture on the structure and function of NmqNOR. The second 
objective is to identify the proton and electron pathway of NmqNOR by analysing the high-
resolution active structure obtained, and through site direct mutagenesis and kinetic studies by 
inhibitors. From the kinetic study, a NmqNOR-inhibitor structure complex is needed in order 
to fully understand the mechanistic mechanism of how proton transfers from the electron donor 
site towards the active site.
The thesis covers six chapters. Chapter 2 presents descriptions and discussions on 
experiments involving purification, crystallization and X-ray diffraction on the NmqNOR. The
highlight of Chapter 2 is the successful purification of active structure of NmqNOR and 
crystallization of the protein, where the diffraction obtained was 3.15 Å as measured using
SPring-8 beamline. Few crystallization methods were applied, and the final crystal was
obtained by hanging drop method (vapour diffusion). However, the crystal structure obtained 
was not in native form as zinc binds at the entry and final part of proton pathway of NmqNOR. 
Chapter 3 provides description of a further experiment using Cryo-Electron Microscope where
samples were measured in the solution directly after purification. Cryo-EM is a state-of-the art
and powerful tool used to obtain native structures of enzyme. In the experiment done at the
University of Leeds, a relatively high-resolution structure at 3.06 Å was obtained. Results
discussed in Chapters 2 and 3 were analysed and published in IUCR journal (Jamali et al., 
2020). Using high resolution data obtained from experiments discussed in these chapters, the
putative proton pathway, the electron transfer pathway and the catalytic site structure of 
NmqNOR were successfully identified. This leads to the final objective of the study which is
to identify the property of the electron pathway of this enzyme. This was achieved through a 
site-direct mutagenesis study and kinetic study of NmqNOR with the electron pocket inhibitor.
9
  
        
    
       






























All data are compiled and discussed in chapter 4. Apart from the kinetic study in chapter 4, 
Chapter 5 shows the early data on NmqNOR-inhibitor structure complex progress. However, 
at the time of this thesis being written, we only successfully obtained NmqNOR structure with 
one type of inhibitor at 3.10 Å using Cryo-EM. All data and results are summarised in chapter 






          




      
        
          
        
      
   
      
       
  
       
     
           
        
          
  
 
     
         
       
      
        
      
      
    
       
CHAPTER TWO
Crystal Structure of Zinc Bound Nitric Oxide Reductase from N.
Meningitidis by X-ray Crystallography
2.1 INTRODUCTION
NORs are essential components of anaerobic nitrate respiration, called denitrification, 
in bacterial cytoplasmic membrane, and are responsible for the reduction of nitric oxide (NO) 
to nitrous oxide (N2O); 2NO + 2H+ + 2e-→ N2O + H2O, at the heme and non-heme iron (FeB) 
binuclear center (Tomoya Hino et al., 2010; Matsumoto et al., 2012; Terasaka et al., 2017).  
Three types of respiratory bacterial NOR have been identified namely cytochrome c-dependent
NOR (cNOR), di-copper NOR (CuANOR) and qNOR (Hendriks et al., 2000; Tomoya Hino et 
al., 2010; Matsumoto et al., 2012; Shiro et al., 2012; Al-Attar and De Vries, 2015). Currently, 
cNOR is the most widely studied and is found in denitrifying organisms as a respiratory 
enzyme. Unlike cNOR, qNOR can be found in both denitrifying and non-denitrifying bacteria. 
qNOR is present in several pathogenic bacteria including the Gram negative, human 
pathogenic bacterium, Neisseria meningitidis, as an enzyme responsible for detoxification of 
NO produced by the host (Hendriks et al., 2000; Muna F Anjum et al., 2002; Rock and Moir, 
2005). These bacteria are borne by about 10% of the world’s population in a non-virulent, 
asymptomatic type that can grow into a pathogenic infection that may affect more than a
million people (Pizza and Rappuoli, 2015).
The biochemical study and determination of the high-resolution structure of qNOR 
from N. meningitidis (NmqNOR) is crucial to provide a framework for developing a
knowledge-based strategy for designing new antibacterial drugs, as well as an important means
to understand the chemistry of NO reduction by NOR. One of the powerful methods to 
understand the full structure of protein is X-ray crystallography. This technique requires the
protein to be mixed with the precipitants such as salts, polyethene glycols, polyalcohols and 
glycerol, in which water will be removed from the solution and protein will precipitate into 
crystalline form (McPherson and Gavira, 2014; Liebschner, 2018). The X-ray crystallography 
method is applied in the vapour diffusion method where the water present in the protein is
11
  
    
          
        
    
        
         
   
 
 
    
        
     
     
      
          
        
       
    
           
          














dehydrated into the reservoir’s solution. The traditional approach of crystallisation of 
membrane protein provides a challenge as detergent used in the purification may cause a loss
in the native lipid and tight constraint into the protein. To address this issue, several
revolutionary techniques were developed recently in the membrane protein crystallography, 
such as lipid cubic phase method and bicelle method where protein is crystallised in the
presence of lipid. This is useful to maintain the native lipid environment in the membrane
protein especially in some protein complex (Faham and Bowie, 2002; Caffrey and Cherezov, 
2009).
A research group from SPring-8 has successfully purified and obtained biochemical
data and a crystal structure of NmqNOR (Gonska et al., 2018). The data obtained showed that
NmqNOR was an electrogenic enzyme based on the respiratory control ratio (RCR) 
experiment. This finding contradicted with the widely studied form of NOR, cNOR, which is 
a non-electrogenic enzyme(Reimann et al., 2007). However, the resolution of the crystal
structure of this interesting enzyme obtained by Gonska et al., 2018 was at 4.5 Å which is
considered as a low resolution structure. In this study, we aim to improve the purity and to 
elucidate the crystal structure of NmqNOR. Three crystallisation protocols were used in order 
to obtain high resolution structure of NmqNOR and the final resolution obtained was 3.2 Å. 
This structure was obtained in the presence of zinc at the putative proton channel. Furthermore, 
a zinc atom was found to be an inhibitor in the proton pathways and this concurs with the








   
    
     
        
          
       
      
        
   
      
    
     
        
     
   





   
           
     





2.2 MATERIALS AND METHODS
2.2.1 Purification of NmqNOR
Wild type of NmqNOR was overexpressed in E. coli C43 (DE3) (Lucigen) strain and 
pre-cultured in 2xYT (48 g Tryptone, 30 g Yeast Extract, 15 g NaCl) for 16 hours. Pellets from
the preculture were then transferred to LB media (50 g Trypton, 25 g Yeast Extract、 25 g 
NaCl) as the culture media with the addition of IPTG to induce overexpression. Both preculture
and culture conditions were set at 37°C and 80 rpm. Next, the pellet harvested from the culture
was agitated with 100 mL (final volume) membrane buffer (2 pellets of EDTA-free protease
inhibitor (Roche), 1 mL of 20 mg/mL lysozyme, 1 mL of 10 mg/mL DNase, 1 mL of 1 M
MgCl2, 1 mL of 0.5 M EDTA pH8.0) for 1 hour. All cells in the buffer were then disrupted 
with French press (Ohtake) and proceeded with two times ultra-centrifugation (Hitachi) in 
order to obtain the protein membrane. The protein membrane was solubilized with 1% of n-
dodecyl-ß-D-maltoside (DDM, Dojindo) in solubilization buffer (50 mM Tris pH8.0, 150 mM
NaCl, 10% Glycerol 1% DDM). Sample was applied to Ni-NTA column chromatography in 
order to cleave the his-tag in the attached in the c-terminal of NmqNOR. The detergent was
changed to n-decyl-ß-D--thiomaltoside (DTM, Anatrace) in the size exclusion chromatography 
(SEC). For cryo-EM experiment (Chapter 3), NmqNOR was fused with the fusion protein of 
apocytochrome b562 (Bril) in order to stabilize and increase the molecular weight during cryo-
EM measurement.
2.2.2 UV-visible spectra measurement
UV-visible spectra of NmqNOR were measured using Jasco-V630 Spectrophotometer. 
All measurements were made using a quartz cuvette whereby wave scans of samples were
performed across 250-700 nm with 1 nm step. Preparation of reduced qNOR were performed 
in an airtight quartz cuvette with a rubber seal. Samples were reduced by the addition of 5 mM






    
       
       
          
      
         
          





      
     
      
    
         
         
     
   
      
  
          
        
         
     
    
        
    
      
 
2.2.3 Measurement of NO consumption by NmqNOR 
NO reduction activity was determined using an NO electrode (World Precision 
Instrument (WPI) inc.) at room temperature (Figure 4.2). The buffer contained, 50 mM
HEPES-Na pH 8.0, 150 mM NaCl and 0.05% (v/v) DDM, which was made anaerobic by 
oxidation of 1 M glucose by 10 µL/mL glucose oxidase with 10 µL/mL catalase inside the final
buffer solution. The sample was then incubated (with gentle stirring) for about 5 minutes to 
ensure all the oxygen was consumed via the glucose oxidation process. NO buffer was made 
in a glass vial by replacing the air inside with N2 gas and then bubbling NO gas into 5 ml 50 
mM HEPES pH 8.0, 150 mM NaCl and 0.05%(w/v) DTM buffer for 20 minutes, to achieve a
saturated NO solution (~ 2mM).
2.2.4 Protein Crystallization, data collection and structure determination
NmqNOR crystals were grown from both peaks of size exclusion chromatographic
fractions. Three methods were used in order to obtain crystal structures of NmqNOR, namely 
lipid cubic phase (LCP), bicelle crystallization and vapour diffusion. For the LCP method, the
reservoir used was from the screening kit of Molecular Dimension (Memeso, Memgold, 
Memgold 2 and Memtrans) while plate set up was done by a Gryphon LCP robot (ARI). For 
the bicelle crystallization, the protocol was done by following the guide given by the
manufacture in Memmagic kits (Molecular Dimension). Hanging drop protocol was used in 
the vapour diffusion method, with 10 mg/mL protein concentration and a reservoir condition 
of 50 mMHEPES pH 8.0, 26% PEG 600 (v/v) and 0.5 mMZnSO4. Crystals were cryoprotected 
in 20% glycerol and subsequently flash frozen and stored in liquid nitrogen. Diffraction data
was obtained at BL44XU beamline at SPring-8, Japan at 100 K with a CCD detector to 3.0 Å
resolution with 0.9 Å wavelength. For structural analysis, two data sets from two different
crystals were combined, to improve completeness at low resolution. Both data sets were
processed by iMosflm (Battye et al., 2011) and then scaled using Aimless (Evans and 
Murshudov, 2013). Structure was solved by molecular replacement with MOLREP (Vagin and 
Teplyakov, 2010) using the cryo-EM structure of wildtype AxqNOR as a starting model
(PDB:6QQ5). Structure was refined by REFMAC 5 (Murshudov et al., 2011) and manually 
rebuilt with COOT (Emsley and Cowtan, 2004). Data collected from this work and the








   
  
  
          
        
     
     
      
         
     
   
       
          
          
       
       
     
          
     
      









2.3 RESULTS AND DISCUSSION
2.3.1 Purification and oligomerization of NmqNOR
NmqNOR was overexpressed in E. coli and purified using nickel-NTA column 
chromatography and size exclusion chromatography. During size exclusion chromatography, 
NmqNOR displayed a dimer-monomer mixture upon elution, with majority of protein in ‘peak 
1’ fraction as shown in Figure 2.1(A). This behaviour was not due to detergent exchange from
DDM to DTM, as the migration was essentially identical. To assess the oligomeric state, we
subjected the samples; ‘peak 1’ and ‘peak 2’ fractions to non-denaturing gel electrophoresis
(Blue-Native PAGE). Predominantly, peak 1 migrated to ~ 242 kDa (which was consistent
with a dimeric NmqNOR (90 kDa x 2) + detergent micelle (~ 60 kDa)), whilst peak 2 migrated 
between 66 kDa and 146 kDa. The result indicated that both peaks had a slightly mixed species
when sample concentration was increased, as shown in Figure 1(B). NO reduction of each peak 
was conducted, with peak 1 exhibiting higher steady state NO reduction activity compared with 
the sample derived from peak 2 (Figure. 1(C)). This behaviour was similar to AxqNOR but in 
contrast to bovine cytochrome c oxidase (CcO), where the activity of the monomeric species
has been found to be twice that of the dimeric form (Gopalasingam et al., 2019; Shinzawa-Itoh 
et al., 2019). The latter has recently been observed in crystal structures, where a monomeric
bovine CcO structure has been reported (Shinzawa-Itoh et al., 2019). Metal content
measurement was done after purification for both peak fractions of NmqNOR, showing the
three iron atoms and no zinc was present in the sample solution. Non-heme iron was present in 
both peaks at full occupancy. UV-Visible absorption spectra (oxidized and reduced) showed 
similar band positions from both peak fractions, indicating electronic structures of the active







    
         
         
  
      
    
  
        
      
    
   












Figure 2.1: Biochemical characterization of NmqNOR. (A) Size exclusion chromatography 
of NmqNOR. Solid curve shows trace at 280 nm absorbance of the BRIL construct of NmqNOR 
and broken curve shows the one fromwild typeNmqNOR. Two type of fractions were observed 
in both constructs, which are indicated by labels `P1` for dimer and `P2` for monomer (red 
dashed line shows divide between peak 1 and peak 2), (B) Blue-Native gel experiment for both 
fractions (P1 and P2) after concentration in 100 kDa cut-off centrifugal filtration devices
(Amicon). Both 5 µg (5) and 10 µg (10) of each fraction was loaded onto the gel. Peak 1 
samples migrate as the higher molecular weight species (~242 kDa), whilst peak 2 samples
migrate between 66 and 146 kDa. Two bands of the high and low molecular weight species
could be observed in both peak fractions when loaded with 10 µg sample, which indicate a
slight mixture of monomer and dimer in both peak 1 and peak 2. M= Native-PAGE marker, 
with values corresponding to molecular weight in kDa, (C) NO reduction activity measurement
of both peak 1 and peak 2 fractions. Peak 1(solid curve) shows higher NO reduction activity 














Figure 2.2 UV visible absorption spectra of purified NmqNOR. Oxidized (solid curve) and 
dithionite reduced forms (broken curve) spectra are shown for peak 1 (a) and peak 2 (b) 
chromatographic fractions following purification, with the Q-band region of the spectra shown 
inset. Proteins were stored in 50 mM HEPES pH 8.0, 150 mM NaCl, 0.05 % (v/v) DTM. 
Spectra are consistent with previous data from Gonska., et al, 2018. 
 
 
2.3.2 Crystal structure of NmqNOR 
 
As stated in Section 2.2, several crystallisation methods were used to obtain the highest 
resolution diffraction of NmqNOR crystal. In the LCP method, several types of lipids were 
used in different screening kits from Anatrace and possible crystal conditions obtained are 
shown in Figure 2.3 (A,B and C). All crystals were measured on the BL32XU microfocus 
beamline at SPring-8. All LCP crystals showed no diffraction spots. The second method used 
for NmqNOR crystallization was bicelle crystallization. This method was previously 
successfully used in the crystallization for bacteriorhodopsin (Faham and Bowie, 2002). Figure 
2.4 (A and B) shows two different conditions obtained using this method with the highest 






















Figure 2.3. LCP crystallization of NmqNOR. A) shows crystal grown in monolinolein with 
reservoirs 27% v/v Polyethylene glycol 400, 100 mM HEPES; pH 6.9 150 mM Ammonium 
fluoride, 2.5% v/v Jeffamine® M-600. B) shows long needle shape crystal in monolinolein 
with reservoirs 27% v/v Polyethylene glycol 400, 100 mM HEPES; pH 6.9 150 mM 
Ammonium fluoride, 2.5% v/v Jeffamine® M-600. C) shows another shape of crystal obtained 
in monooline with condition 23% v/v Polyethylene glycol 400, 100 mM tri-Sodium citrate; pH 








Figure 2.4. Bicelle Crystallization of NmqNOR. Figure shows two shape crystal obtained in 
the bicelle lipid crystallization. Both used the same protein concentration with (A) contain the 
reservoir 40% bicelle, 0.01 M Magnesium chloride hexahydrate 0.045 M Magnesium acetate 
tetrahydrate 0.08 M HEPES 7.5 2 0 % v/v PEG 400 2.5 % w/v PEG 4000 2.5 % w/v PEG 8000. 


















Figure 2.5. Vapour diffusion Crystallization of NmqNOR. Figure (A) shows two crystal in 
dark brown colour obtained in the hanging drop method. Crystal obtained initially grows in 
Memgold screening kit and optimize with final condition of 50 mM HEPES pH 8, 26 % PEG 
600 (v/v) and 0.5 mM ZnSO4. Meanwhile (B) shows the diffraction spot obtained in BL44XU.  
 
The best, highly diffracting crystals of NmqNOR only grew in the presence of zinc 
sulphate, under the hanging drop method crystallisation condition as shown in Figure 2.5 (A). 
Crystals diffracted to ~3 Å (Figure 2.3b) allowed me to refine the structure with a 3.15 Å 
resolution in P212121 space group (refer to Table 2.1), revealing only a monomer in the crystal 
lattice. The crystallisation condition was similar with a bacterial CcO, where higher resolution 
crystals were only obtained in the presence of divalent metal cations (Qin et al., 2007). The 
overall monomeric structure of NmqNOR contained 14 transmembrane helices (TM) and the 
position of heme b, heme b3 and FeB were well-defined as shown in Figure 2.6. FeB was ligated 
by three conserved histidines namely His-490, His-541 and His-542. Two Zn2+ binding sites 
were also observed, of which binding locations ‘Zn1’ and ‘Zn2’ were particularly important in 
order to understand the properties of the proton pathway. Zn1 was positioned near TMII, close 
to the predicted entry of water channel and was ligated by His-257, Glu-576 and His-577, as 
in Figure 2.7(A). ’Zn2’ ion was bound by three-carboxylate groups from Glu-494, Glu-498 and 
Glu-563, which were located towards the end of putative proton transfer water channel. Glu-
494 was located too far off for coordination of FeB (refer to Figure 2.7 (B)). Cavity search done 
for this region showed the presence of a big cavity (green colour) from the cytoplasmic region 
towards the ZN2 position as shown in Figure 2.8. Using cavity mode in Pymol software 
revealed several cavities near Ser-252, Thr-255, Glu-259, Tyr-575, Glu-576 and Ser-579. 
These are in the same positions as the Zn1 binding positions to His-257, Glu-576 and His-577 
(refer to Figure. 2.7(A)).  
A B 
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  NmqNOR (PDB ID:6L1X) 
Data collection   
Space group P212121 
Cell dimensions     
    a, b, c (Å) 96.12 116.68 123.55 
    a=b=g  (°)  90 
Resolution (Å) 49.87- 3.10 (3.31- 3.1) * 
Rsym or Rmergea 0.11 (0.556) 
Rpim 0.083 (0.42) 
Mean (I / (s)I)) 6.5 (2.2) 
CC1/2 0.995 (0.207) 
Completeness (%) 83.3 (84.5) 
Redundancy 4.1 (4.0) 
Wilson B-factor (Å2) 60.9 
Refinement 
Resolution (Å) 49.92 – 3.15  
No. Reflections  19034 
Rwork / Rfreeb  0.25/0.30 
No. Atoms  5655 
Protein  5563 
Water  1 
       Zn  3 
Free Fe  1 
  Ca  1 
B-factors (Å2)  
Protein  102.82 
Water       65.67 
Zn ions      121.47 
     R.M.S. deviations   
Bond lengths (Å) 0.0037 
Bond angles (°)     0.994 
Clash score      18 
MolProbity score 3 
Poor rotamers (%) 7.5 
Ramachandran Plot 
Favoured (%) 92.55 
Allowed (%) 6.02 



























Figure 2.6. Overall Crystal Structure of NmqNOR.  Monomeric NmqNOR crystal structure 
with three Zinc (grey spheres) binding sites (Zn1, and Zn2), periplasmic (Peri’) and 
cytoplasmic (Cyt’) ends of lipid bilayer marked with blue dash line. This structure contains 14 

































Figure 2.7. Zinc binding position in Crystal Structure of NmqNOR. Zn1 binding site near 
the proposed proton entry site at the cytoplasmic end,  2Fo - Fc density map is shown as a blue 
mesh, with Zn1 ligated by H257 (contoured at 1.9 s), E573 (contoured at 2.4 s s , E576 
(contoured at 3  s) and H577 (contoured at 2 s) (salmon sticks), (c) Zn2 is located close to the 
binuclear center (heme b3 and FeB (brown sphere), where it is bound by three conserved 
glutamates (E498 (1.5 s),E494 (1 s) and E563 (1 s)). FeB is ligated by only three histidines 
(H490, H541, H542; all contoured at 1.5 s), with extra density between the heme b3 iron and 
























Figure 2.8. Water Cavity in putative proton pathway channel. NmqNOR Zn-bound crystal 
structure putative proton transfer channel (cavity shown as green surface), PyMOL cavity 
detection radius= 3 solvent radii and cavity detection cutoff= 4 solvent radii. 
 
2.3.3 Effect of metal ion toward NO reduction activity and oligomerization of NmqNOR 
 
To find out the effect of zinc binding as observed in the crystallographic structure of 
NmqNOR, we tested several divalent metals, including Zinc on NO reduction of both NmqNOR 
and AxqNOR. The results, tabulated in Table 2.2 show that the presence of zinc eliminated NO 
reductase activity for both enzymes, while the presence of other divalent cations, such as 
magnesium and calcium, did not significantly reduce this activity. These findings are 
comparable to that of CcO, in which both zinc and cadmium are potent inhibitors of the 
enzymatic activity, where the zinc and cadmium bind tightly in the proton pathway entrance 
(Kazumasa Muramoto et al., 2007; Qin et al., 2007), suggesting that qNORs also suffer from 
proton transfer inhibition due to zinc/cadmium binding.  
The effect of zinc binding toward the oligomerization of monomer and dimer of 
NmqNOR was also examined. Peak 1 (dimer) was incubated with several metal for 12 hours 
(overnight) and then ran in the native gel as shown in Figure 2.9 A. In the all cases, there are 
both monomer and dimer fractions; however, the band that resulted from incubation with 
MgCl2 and CaCl2 shows the dimer band with higher intensity than that of monomer. In sharp 
contrast to this, the dimer band was predominant as compared with the monomer band in the 
sample incubated with ZnCl2. Further analysis of the effect of zinc binding by size exclusion 
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chromatography indicated that higher zinc concentration induced more prominent conversion 
from dimer to monomer as shown in Figure 2.9 B. This biochemical study on the effect of zinc 
metal in the NmqNOR answers the question on how the monomeric structure of NmqNOR was 
obtained in the crystal structure.  
 

















Metal ion NmqNOR Activity  
(μmol-NO/s/μmol- 
qNOR) 
AxqNOR Activity  
(μmol-NO/s/μmol- 
qNOR) 
No Metal 37 ± 2 4 ± 0.5 
MgCl2 35.1± 2.4 3.4 
CaCl2 33.7± 1.8 3.2 
ZnCl2 N.D N.D 
ZnSO4 N.D N.D 
















Figure 2.9. Effect of metal toward dimerization of NmqNOR. A show blue native gel from 
overnight incubated dimer fraction (peak 1) in different metal contact. Peak 1 sample migrates 
as the higher molecular weight species (~242 kDa), whilst peak 2 samples migrates between 
66 and 146 kDa. M is lane for marker, lane 1 is sample incubated with 1.0 mM ZnCl2, lane 2 
was incubated with 0.5 mM ZnCl2, lane 3 and lane 4 was incubated with 1.0 mM MgCl2 and 
CaCl2 respectively. Sample incubated with zinc shows higher intensity of monomeric fraction 
while sample with MgCl2 and CaCl2 shows higher in dimer fraction. B shows the formation of 
peak 2 in different concentration of Zn present during the incubation period. The higher 





























Crystal structure of NmqNOR was elucidated at 3.2 Å resolution which is much better 
than that previously achieved by Gonska et al., 2018. Current X-ray structure showed that FeB 
in the active site was ligated by three histidine residues and not by glutamate, which is 
consistent with previously published qNOR structures (Matsumoto et al., 2012; Gopalasingam 
et al., 2019). The overall structure displayed the presence of zinc atoms from the crystallization 
mother liquid, which led to the finding that zinc serves as the inhibitor and affects the 
oligomerisation state of NmqNOR. A close look at the zinc binding positions in the structure 
indicated that the Zn1 and Zn2 were located at the entry and the end of the putative proton 
pathway, respectively. It is highly plausible that zinc binding suppresses the transfer of the 
catalytic protons through water channel. Thus, the structure of NmqNOR was successfully 
determined with the proton pathway inhibitor. The next step is to obtain the native structure of 
















Native Structure of Quinol-Dependent Nitric Oxide Reductase from 




Single particle analysis (SPA) in Cryo-Electron Microscope (Cryo-EM) has 
revolutionised the field of structural biology in recent years. So called `resolution revolution` 
were initiated by advancement of the direct electron detector (DED), heterogenous sample 
preparation by vitrification method and the development of computational program that uses 
complex algorithm to resolve the image obtained(Kühlbrandt, 2014). Previously, the structural 
analysis by cryo-EM was limited to protein with larger molecular weight, but recent 
publications showed that this technique was applicable to solve 3D structure of proteins that 
have less than 100 kDa in size(Liu et al., 2018; Liu, Huynh and Yeates, 2019; Safarian et al., 
2019). The resolution of structures obtained in cryo-EM are in progress day by day. For 
example, by using Jeol CryoARM 300 microscope equipped with a cold field emission gun 
electron (FEG) source and an energy filter, the protein structure was solved at a resolution of  
1.54 Å (Hamaguchi et al., 2019; Kato et al., 2019), but the record was updated (until May 
2020) to 1.2 Å of apoferritin structure by optimized FEG source, new falcon 4 DED, and new 
energy filter that causes improved in signal to noise ratio (SNR) (Nakane et al., 2020).  
 
First step in SPA was the improvement of a vitrification of samples. Vitrification of 
samples means the process for creating thin vitreous ice layer on the cryo-EM grid. This 
method need to be done instantaneously in order to prevent formation of crystalline ice on the 
surface of the grid. Development of recent DED mainly helps during the data collection of 
Cryo-EM. Currently, there are two modes called integrating and counting modes in the data 
collection with DED. In the integrating mode, all the electrons were collected when it hit the 
detector during the entire exposure time. Using this mode, the data can be collected by higher 
dose rate with the short exposure time (Kuijper et al., 2015). This mode was mainly developed 
in a Falcon II by Thermo Fisher Scientific (FEI). In the counting mode that is used in a K2 
Summit detector by Gatan, electrons were counted individually as they hit the detector. This 
will cause less noise during the data collection but it took more time. In 2019, both Gatan and 
 28 
FEI developed new detectors (K3 summit and Falcon III) that have both modes for data 
collection. In addition to the advancement of the hardware, recent developments in data 
processing software are also key to the resolution revolution, inspired by J. Frank et al. who 
applied a method to compile all the large particle images and merge all the orientation observed 
into a 3D model(Frank, Verschoor and Boublik, 1981). Since then, a variety of software has 
been developed in order to improve the data processing of SPA. Software in data processing 
of SPA is mainly designated to handling raw micrographs obtained after data collection, 
particle selection for 2D and 3D classification, orientation refinement and reconstruction of the 
model (Voss et al., 2010). In this chapter, RELION 3.0, consisting of packages of software 
required for structural determination by cryo-EM technique (Zivanov et al., 2018), was used. 
 
The first structural example of the active form of qNOR from Alcaligenes 
(Achromobacter) xylosoxidans (AxqNOR) was obtained by using Cryo-EM method, in which 
the structures were determined at a resolution of 3.2 Å for a valine-495 mutant and 3.9 Å for 
the wild type(Gopalasingam et al., 2019). A xylosoxidans is a denitrification bacteria, and 
AxqNOR functions to reduce NO to N2O as a part of the denitrification systems. The key 
finding of this work is that the dimer formation is also observed in AxqNOR as seen in 
NmqNOR (Chapter 2). Gopalasingam at al. showed clear active site structure and putative 
water channel. The FeB in the AxqNOR structure was ligated by 3 histidine resiudes but not by 
glutamate, which is similar to the previous structure of inactive GsqNOR but different from 
PacNOR where FeB ligated by 4 ligands (three histidine residues and one glutamate residue) 
(T. Hino et al., 2010; Matsumoto et al., 2012; Gopalasingam et al., 2019).  
 
As the results in chapter 2 show that the crystallographic structure of NmqNOR contains 
inhibitory zinc, we tried to solve the native structure of NmqNOR by Cryo-EM, inspired from 
the AxqNOR results. The data from the dimeric fraction showed that the final resolution 
obtained by Cryo-EM was 3.1 Å, which is high enough to discuss details of the active site and 
predict the putative water channel. The active site of the structure for active NmqNOR is 
somewhat different from that of the inhibitor-bound form as the FeB was ligated with 4 ligands. 
In this chapter we also discuss in detail, a possible cavity present that may be indicative of the 
proton pathway for native NmqNOR. 
 
 
3.2 MATERIALS AND METHODS 
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3.2.1 NmqNOR-BRIL Construction and Purification 
 
NmqNOR were fused with the fusion protein of apocytochrome b562 (Bril) with 
molecular weight of 10.9 kDA in order to stabilize and increase the molecular weight for Cryo-
EM measurements (Figure 3.1 (A))(Chun et al., 2012). As shown in (Figure 3.1 (B)) Bril was 
fused at the C-terminal of NmqNOR (NmqNOR-Bril) as with the successful example of 
AxqNOR (Gopalasingam et al., 2019). NmqNOR-BRIL was overexpressed and purified in a 















Figure 3.1 Bril construct in NmqNOR. (A) Construct layout for NmqNOR-BRIL. NmqNOR-
BRIL contains a 3C protease cleavage site (‘3C’), to facilitate the cleavage of the decahistidine 
tag. N- and C-termini are indicated with N and C, respectively. 3C region will be digested with 















3.2.2 Cryo-EM Sample Vitrification and Data Acquisition 
 
Prior to cryo-EM screening, negative stain screening was performed to confirm the 
suitability of the sample for cryo-EM analysis (Fig.3.2(A)). For cryo-EM data collection, 3 µL 
of NmqNOR-BRIL (peak 1) at 4 mg/mL was applied to glow discharged (Pelco) R1.2/R1.3 Cu 
Holey carbon grids (Quantifoil). Grids were then blotted using a blot force of 6, for 6 seconds 
and then plunge frozen into liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific), 
maintained at 4oC with ~ 98 % humidity. Screening and data collection took place using a Titan 
Krios (Thermo Fisher Scientific) at the Astbury BioStructure Laboratory (University of Leeds, 
U. K.), operating at an acceleration voltage of 300 kV, equipped with a K2 Summit Detector 
(Gatan) in counting mode. Imaging was performed at a nominal magnification of 130,000x, 
leading to a calibrated pixel size of 1.07 Å/pixel. A total of 3,182 movies were recorded. The 
dose rate was 8.68 e-/Å2/s-1 recorded over 8 seconds, captured in 40 frames, resulting in a total 
dose of 69.44 e-/Å2, with a defocus range from – 1 to -3.5 µm. Data collection was performed 




































Figure 3.2 Figure shows the observe NmqNOR on the grid by the Microscope. (A) shows 
the homogeneous distribution of NmqNOR on the negative stain microscope. This 
measurement was done prior to Cryo-EM experiment in order to make sure the protein was 
stable on the grid. (B) shows the distribution of 4mg/ml of NmqNOR on the grid during grid 
screening, particles observed were not too crowded and were widely distributed throughout the 
grid. (C) initial particle picking in the micrograph to generate the template for the autopicking 
for all micrographs. 200-pixel box size was used to pick a single particle of NmqNOR. (D) 
particles in all micrograph were picked by using the template prepared before, total ~ 970,000 
particles were extracted including junk, which were later removed during particle sorting and 
2D classification. 
 
3.2.3 Image Processing of cryo-EM movies 
 
All image processing was performed in RELION 3.0 (Zivanov et al., 2018), unless 
stated otherwise. Movies were motion corrected (with dose-weighting) using RELION 3.0 
MOTIONCORR. CTF estimation was performed using CTFFIND 4.1.10 (Rohou and 
Grigorieff, 2015). An initial 2,100 particles were manually picked to generate templates for 
autopicking of all micrographs (Fig.3.2(C)). After autopicking, ~ 970,000 particles were 
extracted (200-pixel box size), which were then subject to particle sorting to eliminate ‘junk’ 
particles (Fig.3.2(D)). After sorting, ~ 800,000 particles were subject to 2D classification (4 




and elements of secondary structure (Fig. 3.3). An initial model was generated (C1 symmetry) 
which was then used during 3D classification (K= 4, 10 Å expectation step limit) upon filtering 
to 50 Å (Fig. 3.4). The best classes from each round of classification served as references for 
the next round. After 4 rounds of 3D classification with the previous settings, two rounds (K= 
3, no expectation step resolution limit) of classification left the best class composed of 233,556 
particles. 3D auto-refinement of this class lead to a resolution of 4.2 Å in C1 symmetry, with 
map sharpening yielding a 3.9 Å reconstruction. Refinement in C2 symmetry led to a resolution 
of 3.7 Å, with map sharpening using a tight solvent mask (excluding the detergent belt and 
BRIL molecules, with 6 pixels cosine edge added) improving the resolution to 3.4 Å. These 
particles were then subject to CTF refinement, with CTF parameter fitting and per particle 
defocus values re-estimated. Refinement and map sharpening led to a map of 3.5 Å resolution, 
before Bayesian particle polishing was performed using all movie frames and parameters 
previously determined from a training step which used 25,000 particles. The ‘shiny’ particles 
were auto refined to 3.3 Å, with map sharpening using a tight mask leading to a final resolution 
of 3.06 Å. All resolution estimates were calculated using the ‘gold standard’ Fourier Shell 
Correlation (FSC)= 0.143 (Scheres and Chen, 2012). ResMap v.1.95 (Kucukelbir, Sigworth 
and Tagare, 2014) was used to assess slice through local resolution estimates, using the default 
finest and coarsest resolution limits (2x and 4x pixel size, respectively). Map volumes and 
masks were visualised in UCSF Chimera v.1.13.1 (Pettersen et al., 2004).  
 
3.2.4 Model Building and Refinement of cryo-EM structures 
 
The X-ray model of NmqNOR (from this work) was rigidly docked into the final cryo-
EM map using UCSF Chimera ‘Fit in Map’ function, before visualisation in Coot. In parallel, 
ARP/wARP (Langer et al., 2008) EM webserver (www.arpwarp.embl-hamburg.de) was also 
used to ab initio build the model. ARP/wARP correctly identified and positioned 96% of the 
residues. When manual model building took place, the missing loop regions on the cytoplasmic 
side and modified helices were taken from the ARP/wARP EM webserver model.  Once built, 
the model was real space refined using Phenix v.1.15 real_space_refinement module (Afonine 
et al., 2018), imposing secondary structure and non-crystallographic symmetry (NCS) 
restraints. Model morphing was only performed once at the start of each refinement. After 
several rounds of manual building in Coot and refinement, validation of the model was 
performed using MolProbity (Williams et al., 2018). Cross validation of the refined model was 
performed to test for overfitting (Brown et al., 2015). The refined model was ‘shaken’ by 
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inducing random 0.5 Å shifts in the atomic coordinates, performed in ‘PDB Tools’, within 
Phenix. The shaken model was then refined against the first half map. The shaken-refined 
model was used to calculate the FSC against the same half map used in refinement (FSCwork), 
against the second half map not used in refinement (FSCfree) and finally against the summed 
map (FSCsum). These were performed in Mtriage, within Phenix. The minor difference between 












Figure 3.3. Final 2-Dimensional Classification of NmqNOR. After series of 2D 
classification done on the data collected, twelve final 2D classification were obtained to 
generate 3D classification. Figure shows each class has a different view observed from 









Figure 3.4. 3-Dimensional classification on data collection. Figure shows the improvement 
of resolution in the map by 3D classification. Start on left shows the initial 3D classification 
with C1 symmetry class with 10 Å resolution limit. The middle 3D class shows the C1 
symmetry with final (233,556 particles) with no resolution limit. On right shows the final map 
obtained after C2 symmetry, particle polishing and CTF refinement with mask. Maps threshold 
(0.0339) values taken from UCSF Chimera v.1.14. 
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3.3 RESULT AND DISCUSSION 
 
3.3.1 Native Structure of NmqNOR by Cryo EM 
 
Apocytochrome b562 (BRIL(Chu et al., 2002)) was fused to the non-truncated C-
terminus of NmqNOR to increase the molecular weight to make cryo-EM analysis NmqNOR 
tractable (Fig. 3.1(A) and Fig 3.1 (B)). Previous attempts to gain a reconstruction in the absence 
of BRIL resulted in a ~ 9 Å resolution map, with lack of clear, secondary structure features, 
the results of which were reported in Gopalasingam., et al, 2019. NO reduction activity by 
NmqNOR-BRIL showed no significant difference compared to wild type NmqNOR. After 
negative staining imaging to confirm the homogeneity and integrity of the sample, grids were 
prepared for cryo-EM analysis (Fig. 3.2(A) and Fig. 3.2 (B)). From 3,182 micrographs, 
972,078 initial particles were extracted, before being reduced to 233,556 through iterative 
cycles of 2D and 3D classification (Fig. 3.3, Fig. 3.4, and Fig. 3.5(A)). For the final 3D 
reconstruction with C2 symmetry imposed, a final global resolution of 3.06 Å was achieved, 
as judged by the ‘gold standard’ FSC= 0.143 (Table 3.1 and Fig. 3.6). local resolution estimated 
by RELION 3.0 shows the core part of the map has the highest resolution (Fig. 3.7) and a slice 
through the map by RESMAP show the highest resolution in the core part is approximately 2.5 
Å (Fig. 3.8), importantly where the active site in the qNOR is located. The outer region of the 
map shows slightly lower resolution (between ~3.5 Å to ~4 Å) where few flexible regions were 
located.  The density for the BRIL portion was at a lower resolution compared to the NmqNOR 
molecule, presumably due to BRIL’s flexibility and subsequently was not built into the model 
(Fig. 3.5 A). Final model of NmqNOR was built into map as shown in the Figure 3.9.  Unlike 
the crystal structure (Chapter 2, Fig. 2.6), peak 1 fraction used for cryo-EM revealed NmqNOR 
in a dimeric arrangement, akin to the cryo-EM structure of AxqNOR. This dimeric structure is 
held by TMII of both monomers with four amino acid residues maintaining the interface; Val-
237, Leu-240, Leu-241, and Ile-244 (Fig. 3.10 A). These four residues are highly conserved 







Figure 3.5. qNOR-BRIL construct and unsharpened density maps (A) NmqNOR-BRIL 
cryo-EM dimer reconstruction shown at two thresholds, the top map (0.0063 binarisation 
threshold) shows the BRIL portion of the reconstruction on the cytoplasmic (Cyt’) side. (C)The 
bottom map is shown at 0.0125 binarisation threshold, without the micelle and BRIL 
molecules. Dashed yellow line demark cytoplasmic and periplasmic (Peri’) sides. Map 
threshold values taken from UCSF Chimera v.1.14, with the ‘Hide dust’ tool employed in 
















































*Resolution determined by RELION 3.0, † Mean B-factors determined by Phenix 
 
Parameters Wildtype NmqNOR (PDB ID: 
6L3H, EMDB ID: EMD-0822) 
Microscope and Detector Titan Krios with K2 Summit 
(Gatan) 
Location Astbury BioStructure 
Laboratory (ABSL), U.K 
Voltage (kV) 300 
Magnification 130,000x 
Pixel size (Å) 1.07 
Defocus range (µm) -1.5 to -3.5 
Total dose (e-/A2) 69.44 
No. of frames 40 
Exposure time per frame 0.3 
Dose per frame (e-/Å2) 1.63 
No. of micrographs 3,182 
Total autopicked particles 972,038 
Particles in final 3D refinement 233,556 
Symmetry Imposed C2 
Map Sharpening B-factor (Å2) -91 
Map Resolution* (Å) 
(FSC threshold= 0.143) 
3.06 
Refinement 
Starting model for structure 
refinement 
Zn2+-bound NmqNOR (chapter 
2) 
CC (mask) 0.88 
CC (main chain) 0.88 
CC (side chain) 0.86 
CC (ligands) 0.92 
Non-hydrogen atoms 11,966 






Bond lengths (Å) 0.007 
Bond angles (o) 0.764 
Clash score 4.30 
MolProbity score 1.65 
Poor rotamers (%) 0.16 
Ramachandran Plot 
Favoured (%) 93.22 
Allowed (%) 6.78 




Figure 3.6 Cryo-EM refinement and validation of NmqNOR-BRIL. Top, FSC curves 
(correlation corrected= black, unmasked maps= green, masked maps= blue and phase 
randomized masked maps= red) of NmqNOR-BRIL cryo-EM reconstruction, with ‘gold 
standard’ FSC= 0.143 shown as a broken, black line. Bottom, map-model correlations of 
summed map/FSCsum (purple), half 1 map/FSCwork (gold) and half 2 map/FSCfree (brown), with 
FSC= 0.5 shown as a broken, black line. Validation performed by Mtriage, within Phenix.  
 
The cryo-EM density map was more detailed than the crystallographic electron density 
maps, where heme b, heme b3, FeB and associated ligands able to be modelled with confidence. 
The coordination of the active site in the absence of zinc was observed with cryo-EM, which 
interestingly showed that the FeB was ligated by four ligands; the conserved tri-histidyl ligands 
(His-490, 541 and 542) and Glu-494 (Fig. 3.11 A). The ligation mode of Glu-494 is different 
from the previously reported (inactive) crystal structure of GsqNOR and the active AxqNOR 
structure by cryo-EM, both of which had only tri-histidyl ligand coordination to FeB 
(Matsumoto et al., 2012; Gopalasingam et al., 2019) (Fig. 3.11 B). The orientation of the 
conserved glutamate in EM structure of NmqNOR is similar to Pseudomonas aeruginosa 
cNOR (PacNOR) (Tomoya Hino et al., 2010), except in PacNOR, FeB was coordinated by 
both carboxyl oxygens of the glutamate (distances of 2 and 2.5 Å), while in NmqNOR cryo-
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EM structure, FeB is coordinated by a single carboxyl oxygen (Oe1) from Glu-494, separated 
by 2.4 Å (Fig. 3.11 C).  
 
The higher quality of the structure allowed the putative proton transfer water channel 
in this electrogenic enzyme to be investigated. A large cavity was observed from the 
cytoplasmic region near residues Ser-252, Thr-255, Glu-259, Tyr-575, Glu-576 and Ser-579, 
and towards the active site (Fig. 3.12). This helps rationalise our previous site-directed 
mutagenesis study of the proposed water entry channel, where Glu-259 variants had no 
detrimental effect on the NmqNOR activity, as the channel may be too large allowing some 
potential redundancy in proton pathway(s) (Gonska et al., 2018).  
 
The dimeric structure of NmqNOR is largely held by TMII, similar to AxqNOR. Along 
TMII, structural analysis using PyMOL (Schrodinger  LLC, 2015) revealed a cavity that 
bridges the dimeric interface connecting the two monomers (Fig. 3.12 and Fig.3.13). There are 
several residues which hold this cavity; Tyr-251, Ser-252, Thr-255 and Arg-572. These in turn 
connect with the charged residues that line the putative proton water transfer pathways of the 
respective monomers. This pathway consists of several charged and ionizable residues, starting 
from Glu-259, Ser-579 and His-582, followed by Glu-573, His-577, Glu-576, Ser-523, Thr-
502 and Ala-527 (Fig. 3.11 D). At the end of this putative proton channel, Glu-498 and Asn-
604 lie, which are ligated to each other and may serve as a ‘junction’, responsible for 
controlling the proton before entering the active site.  The importance of Glu-498 was 
demonstrated by the previous study which showed that only mutation at Glu-498 induces loss 
of activity for this enzyme (Gonska et al., 2018). The same effect was found in AxqNOR, as 
well as in Asn-600 (equivalent to NmqNOR Asn-604) being critical for activity (also confirmed 
in Persephonella marina (Pm) qNOR) (Sheraden, 2013), with residues closer to the active site 
of NmqNOR and AxqNOR being more conserved in residue type and orientation, compared to 
lower down (i.e. towards the  cytoplasmic end) the putative proton transfer water channel (Fig. 


















Figure 3.7. Local resolution. 3D reconstruction from cryo-EM filtered and coloured by local 





Figure 3.8. slice through resolution map (bottom) for NmqNOR cryo-EM structure. 
Resolution estimated using the ‘gold standard’ FSC of 0.143, within RELION 3.0. Slice 

























Figure 3.9. Cryo-EM Analysis of the active NmqNOR dimer. NmqNOR dimeric model after 
structure refinement and model building docked into the sharpened cryo-EM derived map (grey 
outline), Chains coloured in purple and cyan cartoon, respectively. Yellow lines mark the lipid 





































Figure 3.10. Consensus TMII residues in qNORs. (A)Dimer interface of NmqNOR is 
mediated by TMII (purple and cyan helices) of each monomer. Residues V237, L240, L241 
and I244 (map contoured at 7s) likely stabilize the dimeric form of NmqNOR.(B) Four amino 
acids residues (Val-237, Leu-240, Leu-241 and Ile-244) that are involved in dimerization of 
NmqNOR are well conserved (> 40 % conservation) amongst the 224 qNOR sequences 
analyzed. Figure prepared using WebLogo v3.0 (Crooks et al, 2004). Probability refers to 








Figure 3.11. Active site configuration and proton transfer channel in dimeric cryo-EM 
structure of NmqNOR (A) Active site of ‘native’ NmqNOR cryo-EM structure with 
corresponding density, showing FeB (brown sphere) to be ligated by four ligands (E494, 
H490,H541 and H542), with E494 contoured at 4 s and Histidine residues at 8 s. E494-FeB 
hydrogen bond shown by red dashed line (2.4 Å) and tri-histidyl-FeB coordination shown as 
black dashed lines.  (B) Comparison between active site structures of PacNOR (transparent 
pink sticks), AxqNOR V495A (transparent magenta sticks) and NmqNOR (cyan sticks), clearly 
showing PacNOR and NmqNOR terminal glutamate (E494) to ligate FeB (black and red dashed 
lines, respectively). E494 may display flexibility as part of its function in proton transfer, as 
AxqNOR equivalent glutamate ligates a water (orange sphere) in lieu of FeB, (C) Top; PacNOR 
(PDB ID: 3O0R) active site, with E211 (equivalent to NmqNOR E494) ligating FeB (purple 
sphere) in bidentate fashion, shown by black dashed lines (distances also shown), Bottom; 
AxqNOR V495A (PDB ID: 6QQ6) active site showing E490 (equivalent to NmqNOR E494) 
ligating a water molecule (‘Wat’; orange sphere), with FeB (yellow sphere) having tri-histidyl 
coordination. (C) Putative proton transfer channel in NmqNOR, with residues shown as cyan 
sticks and contoured at 6 s (aside from E259 and E573, both contoured at 4 s). N604 and E498 
are hydrogen bonded (black dashed line) in the cryo-EM structure, FeB and calcium ions shown 



















Figure 3.12 Monomer portion from the dimer in plane of membrane. Residues Ser-252, 
Thr-255, Glu-259, Tyr-575, Glu-576 and Ser-579 (yellow sticks) may form the start of the 
putative proton water transfer channel (black dashed box) from the cytoplasmic end, right, 
zoomed in portion of the black dashed box, with the cavity (brown surface) originating from 






















































Figure 3.13. Putative proton transfer water channel cavities within NmqNOR cryo-EM 
derived dimeric structure. Above, dimer in plane of membrane, coloured by chain; ‘A’ in 
cyan and ‘B’ in purple cartoon, respectively. TMII marked as roman numeral and residues that 
may partake in synergising proton transfer pathways between each chain are shown as yellow 
sticks (within black dashed box). Bottom, cavity (brown surface) viewed from the periplasmic 
side, showing connectivity between the two chains. Several residues (Tyr-251, Ser-252, Thr-
255, and Arg-572) may help maintain connectivity between both monomers and help form the 
putative proton transfer water channel (shown by purple and cyan sticks, respectively) toward 

































Figure 3.14 Putative proton transfer channels amongst NmqNOR and AxqNOR cryo-EM 
structures. NmqNOR (cyan ribbon and sticks, residues labelled in black) and AxqNOR 
(magenta ribbon and sticks for Val-495-Ala structure, grey sticks for wildtype, differing 
residues labelled in magenta) display more conformational and structural heterogeneity in the 
first half of the putative proton transfer channel, e.g. from E259 till T502 (NmqNOR 
numbering). N604 and E498 show conserved conformations (aside from in V495A for the 
latter, due to increased flexibility) and may form a ‘junction’ for protons to pass through on 
toward E494 and the active site. Note, in AxqNOR structures of wildtype and Val-495-Ala 
(both active), terminal glutamate does not ligate FeB, yet in NmqNOR this glutamate does ligate 












Fig.S2 Putative proton transfer channels amongst NmqNOR and AxqNOR cryo-EM structures.
NmqNOR (cyan ribbon and sticks, residues labelled in black) and AxqNOR (magenta ribbon and sticks
for V495A structure, grey sticks for wildtype, differing residues labelled in magenta) display more
conformational and structural heterogeneity in the first half of the putative proton transfer channel,
e.g. from E259 till T502 (NmqNOR numbering). N604 and E498 show conserv d co formations (aside
from in V495A for the latter, due to increased flexibility) and may form a ‘junction’ for protons to pass
through on toward E494 and the active site. Note, in AxqNOR structures (both active), terminal





Table 3.2 Site directed mutagenesis of qNOR residues situated in putative proton water 
transfer channel 
 
Residue in NmqNOR and % 
activity vs WTa 
 
Residue in AxqNOR 




GsqNOR and % 
activity vs WTc 
 
Residue in 
PmqNOR and % 

















Glu-498-Ala (7 %) 
Glu-498-Gln (20 %) 




Glu-494-Ala Peak 1 (5 
%) 
Glu-494-Ala Peak 2 
(N.D) 
 







Asn-604 (-) Asn-600-Ala (7 %) Asn-622 (-) Asn-586-Leu (N.D) 






Glu-569-Ala (N.E) Glu-591 (-) Glu-555-Leu (80 
%) 
 
(-) = No mutagenesis attempted 
(N.D) = Activity not detected 
(N.E.) = No over-expression of variant 
a= data from Gonska et al., 2018 
b= data from Gopalasingam et al., 2019 
c= data from Matsumoto et al., 2012 











3.3.2 Structural comparison of crystallographic zinc-bound and cryo-EM of NmqNOR  
 
Based on our results, the crystal and cryo-EM structures of NmqNOR have different 
active site arrangements. For the crystal structure, the crystal was grown in zinc containing 
conditions which led to the observation of two Zn binding sites, with ‘Zn2’ binding site 
affecting the conformation of Glu-494. However, in the cryo-EM structure, a native structure 
was observed, as data was collected without any additional buffer components; in which Glu-
494 was ligated to FeB, which could be the natural position for Glu-494 (Fig. 3.15 A). However, 
knowing that the inhibitor (Zn) binds toward the end of putative water channel (Chapter 2 Fig. 
2.7(B)) in the crystal structure, Glu-494 may possess some flexibility between FeB and the end 
of putative proton pathway, as seen in AxqNOR (Gopalasingam et al., 2019). From the overall 
structure, TMII in the crystal structure moved significantly outwards compared with the cryo-
EM structure. The TMII helix is clearly important for maintaining the dimer interface and a 
distortion of this helix may be a driver for the disruption of active dimer (Fig. 3.15 B).  
 
Another possible reason was the location of Zn1 binding present in the earlier part of 
putative proton pathway. Three amino acids which bind Zn1 may be responsible in the putative 
proton pathway and cavity formation/maintenance as observed in the dimeric cryo-EM 
structure, shown in Figure 2.8 (Chapter 2). This binding of ‘Zn1’ might be responsible for 
cavity structure change and affect the position of TMII in the crystal structure. The position of 
His-577 in the cryo-EM structure was moved upwards and Glu-576 (and Glu-573) downwards 
in order to accommodate space for a potential water pathway in the cavity, however, in the 
crystal structure, all three of these residues were binding a zinc (Zn1) atom (Fig. 3.15 C). 
Alignment of the monomer and dimer structures of NmqNOR show that Zn1 binding may cause 
the TMII loop region to splay away and into the symmetry related molecule of the dimer, 
specifically clashing with TMX (Fig. 3.16). This structural change may be an important factor 










Figure 3.15. Comparison of dimeric cryo-EM and monomeric crystallographic NmqNOR 
structures. (A) Crystallographic structure (salmon sticks) Zn2 (grey sphere) binding site 
interferes with FeB (magenta sphere), as E494 is helping coordinating Zn2 (yellow dashed 
lines), whilst the native, non-Zinc bound cryo-EM derived structure (cyan sticks) shows E494 
to ligate FeB (brown sphere) in a monodentate fashion via the Oe1 atom, shown by the red 
dashed line, (B) Alignment of crystallographic (salmon cartoon) and cryo-EM structure (one 
protomer of dimer shown as cyan cartoon) shows distortion of TMII in the crystal structure, 
possibly due to absence of neighboring molecule. TMX is also heavily perturbed possibly due 
to Zn1 binding (black dashed box, elaborated in panel (C)), (C) Zn1 binding causes significant 
helical movement of TMX, with the cryo-EM TMX shifted inwards, with E573, E576 and 
H577 facing toward the putative proton transfer channel/solvent in the absence of zinc, with 










Figure 3.16. Structural comparisons between monomer and dimer structures of qNORs. 
(A) Left, alignment of NmqNOR monomeric, Zn bound structure (salmon cylinders) against 
the cryo-EM dimeric structure of NmqNOR (cyan and purple cylinders). TMII, IX and X 
marked as roman numerals. Right, view from cytoplasmic end shows the distortion of 
monomeric TMII (salmon) away from TMXI, with the loop clashing into TMX of the 
symmetry related monomer (purple cartoon) of the cryo-EM derived dimer. Zn1 (grey sphere) 
binding may cause this distortion and contribute to dimer-monomer transition, with Zn1 
binding ligands shown as salmon sticks. (B)Left, alignment of AxqNOR cryo-EM dimer (teal 
cylinders) against the Glu-494-Ala monomeric cryo-EM structure (orange cylinders), with 
TMI, II, IX and X marked. Right, cytoplasmic end view of helical rearrangements, with the 






3.3.3 Active site structure of NmqNORs 
 
Based on the active cryo-EM structure of AxqNOR and inactive crystal structure of 
GsqNOR, it has been suggested that qNOR FeB is ligated by only three conserved histidine 
ligands. The cryo-EM structure of NmqNOR, like AxqNOR is also dimeric, however FeB has 
four ligands. The activity of NmqNOR is an order of magnitude higher than AxqNOR, which 
may arise from this difference in active site’s ligand environment. We suggest that Glu-494 
(NmqNOR numbering) plays a vital role as a final proton acceptor before transferring it to the 
active site for NO reduction. The flexible nature of this catalytically essential Glu-494 might 
be unique to qNORs and a key property for fulfilling its function for proton transfer either from 
Glu-498 or Glu-563. The result of Zn binding in Zn2 site shows that these three main 
glutamates (498, 494 and 563) were grouped together by Zn binding, in which Glu-494 can 
either receive protons directly from Glu-498 or through Glu-563. Whether the flexibility of 
glutamate facilitates accommodation of two NO molecules for NO reduction in the active site 
remains an open question. 
 
3.3.4 Putative proton transfer water channel. 
 
The use of Zn2+ and Cd2+ ions have been utilised in several membrane protein 
complexes in order to understand their respective proton pathways. These include bacterial and 
bovine CcO, cytochrome bc1 complex and photosynthetic light reaction center (Schubert et al., 
1997; Berry et al., 2000; Kazumasa Muramoto et al., 2007; Qin et al., 2007). Zn binds towards 
the D-pathway in bovine CcO and K-pathway in bacterial CcO, thus as a part of HCuO`s 
family, the properties of Zn and Cd to either bind toward the imidazole ring of histidine and 
three carboxyl groups has proven very useful in order to understand the properties of proton 
pathway in NmqNOR.  ‘Zn1’ and ‘Zn2’ binding sites were crucial in this study, as we predict 
that the Zn1 binding site is at the entrance of the putative proton transfer water channel and 
Zn2 binding represents the end of the channel. Previously, we showed that site-direct 
mutagenesis around the entrance does not have any significant effect on the activity of 







Figure 3.17. Comparison of dimeric structures between NmqNOR and bovine CcO. (a) 
NmqNOR dimer coloured by chain, A in purple and B in cyan cartoon, respectively. Hemes b 
and b3 and FeB are colored in yellow. Entry point of the proton transfer water channels are 
shown by black arrows and TMII marked (roman numerals). (b) Bovine CcO dimer (PDB ID: 
1V54) coloured by chains, A and B in purple, and N and O in cyan cartoon, respectively.  Other 
chains are colored in blue and green. Hemes a and a3 and CuB are colored in yellow. Entry 










The opening cavity of the water channel is formed by several residues (Ser-252, Thr-
255, His-257, Glu-259 and Ser-579). The cavity then moves upwards and broadens between 
Glu-573 and Ser-523. At the end of the putative proton pathway observed in the cryo-EM 
derived structure, it shows that the proton pathway could be controlled by two amino acid 
residues; Glu-498 and Asn-604. This is further validated by the binding of Zn (‘Zn2’ location) 
and the previously reported site directed mutagenesis of Glu-498 which has significant effects 
on activity abolishment. We expect that the putative water channel terminates here, and protons 
are transferred towards Glu-563, mediated by flexible Glu-494. Alternatively, transfer of 
protons occurs directly from Glu-498 to Glu-494, ultimately reaching the active site. The 
monomeric, inactive structure of AxqNOR Glu-494-Ala revealed unexpected structural 
rearrangements at the active site and several helices. TMII undergoes a slight displacement 
while helices, TMIX and TMX, which help maintain the putative proton transfer channel 
revealed a more drastic change (Fig. 3.16 B). The disturbance at the active site probably had a 
knock-on effect on the overall structure of TMX (which holds His-537 and His-538, two of the 
FeB ligands). Interestingly, TMVIII (which holds Glu-494 and His-486 (third FeB ligand)) 
shows little rearrangement, along with TMXII, which holds Asn-600 (shown previously to 
interact with Glu-494). Similarly, with NmqNOR, TMXI movement across and into the 
putative channel may weaken the interaction with the symmetry related TMII (Fig. 3.15 A), 
possibly contributing to dimer-monomer transition. These movements and consequent 
destabilisation of TMIX and TMX helices in AxqNOR-Glu494Ala clearly weaken the dimeric 
arrangement and result in the mutant purifying primarily as a monomer.  
 
Activity measurement of the wild type qNORs show that the dimeric peak obtained 
from SEC had higher activity than the monomeric peak. Structurally, this may be due to the 
TMII that resides close to the entrance of the proton pathway in the symmetry related 
monomers, as was clearly observed in the cryo-EM structure. The dimeric structure may cause 
increased stability of qNORs in maintenance of the proton pathway, and this was clearly seen 
in the distortion of TMII in the monomeric crystal structure where the helix moves outwards 
and away from the rest of the molecule, when compared to the cryo-EM structure (Fig. 3.15(a)). 
However, it is not clear whether this distortion happens due to any effect resulting from zinc 
binding in the Zn2 site in the proton pathway, as seen in the crystal structure. The stability of 
the dimeric structure may synergise the proton pathway of two monomers due to the cavity 
connection mentioned previously. This raises a possibility that the proton entry is shared 
between two monomers and increases the proton passage by way of widening the channels in 
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the dimeric structure. For the related CcO (bovine) however, the monomeric form has been 
found to be more active under a variety of pH’s. In that case, the structure revealed the K-
pathway hydrogen bonded network of water molecules was found to be continuous and 
unrestricted, whereas in the dimeric structures (Fig. 3.17), cholate interrupts this network near 




The high resolution native structure of NmqNOR was successfully elucidated by cryo-
EM method. Active site FeB was ligated by 4 ligands, similar with the previously studied 
PacNOR but different from the AxqNOR. Thus, we concluded that the Glu 494 is flexible and 
aids the proton transfer from the water channel towards the active site during NO reduction. 
From the structure, the putative proton pathway in active form of NmqNOR could be 
successfully understood. A comprehensive study comparing zinc-bound crystallographic 
structure and cryo-EM enabled us to locate the `entry` and `exit` part of putative proton 

























Nitric oxide reductase (NOR) is a membrane-integrated enzyme which contains a 
binuclear center, consisting of heme and non-heme iron as a catalytic site. NOR is widely 
distributed as an essential component of anaerobic respiration in micro-organisms,  so-called 
denitrification(Walter G. Zumft, 1997), and catalyses the reduction of nitric oxide (NO) to 
nitrous oxide (N2O):  2NO + 2H+ +2e- → N2O + H2O (eq.1). Denitrification can contribute to 
the recycling of redox mediators, and thus help generate a proton motive force across the 
cytoplasmic membrane for ATP synthesis. NOR is highly related to aerobic respiratory 
enzymes, cytochrome c oxidases (CcO), through the molecular evolution of the respiratory 
enzymes. Indeed, NORs are a representative of the Heme Copper Oxidase (HCuO) 
superfamily, which include the aforementioned CcO (Sousa et al., 2012). There are three types 
of NOR, cytochrome c dependent NOR (cNOR), quinol-dependent NOR (qNOR) and di-
copper CuA site containing NOR (CuANOR). The most intensely studied bacterial NOR is 
cNOR which is generally found in only denitrifying bacteria (T. Hino et al., 2010; Terasaka et 
al., 2017; Yamagiwa et al., 2018). In addition to their role as respiratory enzymes, qNOR is 
utilized to detoxify antibacterial agent NO generated by inducible NO synthase (iNOS) in 
hosts’ macrophage(Nathan and Shiloh, 2000; Schnappinger et al., 2003) in several pathogenic 
bacteria(Hendriks et al., 2000; Muna F Anjum et al., 2002; Rock and Moir, 2005). This 
detoxification of NO through Eq. 1 gives an advantage in pathogens towards human immune 
systems, and enables them to colonize inside nasopharyngeal tissue, to escape into blood 
stream and cause bacteraemia in humans (Stevanin, James W.B. Moir and Read, 2005). The 
pathogen Neisseria meningitidis (meningococcus), which causes significant morbidity and 
mortality in children and young adults worldwide, through epidemic or sporadic meningitis 
and/or septicaemia, harbours qNOR for protection against the host immune system. Other than 
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N. meningitidis, qNOR is present in Staphylococcus aureus, where in the past two decades 
several drug resistant strains (e.g. Methicillin and Vancomycin resistant S. aureus) appeared 
in hospitals(Loomba, Taneja and Mishra, 2010). S. aureus uses a similar mechanism towards 
combatting NO produced by the phagocyte and reduces NO into nitrous oxide(Nobre and 
Saraiva, 2013; Vitko, Spahich and Richardson, 2015; Favazzo et al., 2019). Understanding the 
mechanism on how detoxification of NO in pathogenic bacteria occurs is crucial for future 
drug discovery, given the scourge of antibiotic resistance in recent years. The qNOR from N. 
meningitidis (NmqNOR) is the target of this study, which has been shown to be an electrogenic 
qNOR with the fastest NO reduction of any reported qNOR thus far(Gonska et al., 2018). 
 
As stated above, NOR is highly related to cytochrome oxidases in terms of the 
structure, function and evolution. In the case of qNOR, its structure and function can be 
comparable to those of cytochrome bo3 oxidase (Cyt bo3) found in Escherichia coli which 
utilises quinol as an electron donor(Welter et al., 1994). Their primary sequences exhibit about 
25% identity, and the overall structures of qNOR (GsqNOR from Geobacillus 
stearothermophilus (2.7 Å resolution, PDB ID: 3AYG (Matsumoto et al., 2012)) and the recent 
cryo-EM structures of NmqNOR (Figure 4.1(A)) (3.1 Å resolution, PDB ID: 6L3H) and 
Achromobacter xylosoxidans qNOR (3.3 Å resolution, PDB ID: 6QQ6 (Gopalasingam et al., 
2019; Jamali et al., 2020))) are similar to that of Cyt bo3 (Fig. 4.1 (B)) (PDB ID: 1FFT). Both 
qNOR and Cyt bo3 require quinol as an electron donor, although qNOR is a NO reductase, 
while Cyt bo3 is an O2 reductase. Electron transfer from quinol to Cyt bo3 has been studied 
extensively(Welter et al., 1994; Yap et al., 2010; Melin et al., 2018), and the quinone binding 
site and electron-transfer pathway were discussed on the basis of crystallographic and 
mutagenesis data. It was believed that there were two quinol binding pockets for Cyt bo3, 
however, recent studies showed there may be only one quinol binding site present in subunit 1 
of Cyt bo3 (Choi, Lin, et al., 2017; Choi, Schurig-Briccio, et al., 2017). The mutations of 
residues Asp75, Arg71, His98 and Ile102 resulted in total loss of the activity, and Asp75 is 
likely a proton acceptor from quinol(Welter et al., 1994; Abramson et al., 2000; Yap et al., 
2010; Choi, Lin, et al., 2017). The reaction mechanism of quinol (UQH2) oxidation by Cyt bo3 
has been proposed, based on its 3-dimensional structure and biochemical studies using a non-
competitive inhibitor, 2-heptyl hydroxylquinoline N-oxide (HQNO) and a competitive 




In contrast, structural and functional studies of the electron transfer from UQHn (quinols 
of varying isoprene tail length (n)) to qNOR remains to be elucidated.  The structure of 
GsqNOR in the inhibitor-bound form provided structural information for a possible quinol-
binding site, but functional conclusions could not be drawn as the enzyme was inactive due to 
the substitution of non-heme iron (FeB) with zinc (Zn) during detergent exchange(Matsumoto 
et al., 2012). To fill this crucial gap in qNOR knowledge, we prepared active qNOR from N. 
meningitidis, which retains FeB, and studied NO reduction reaction kinetics with three electron 
donors; ubiquinol-1 (UQ1), menadiol (MD) and Phenazine Methosulfate (PMS) kinetically and 
spectrophotometrically. Comparison of the results between qNOR and Cyt. bo3 provide 
valuable information for understanding the electron transfer mechanism, and would provide 
further insight details towards detoxification of NO by pathogenic NmqNOR and also 















Figure 4.1. Overall l structure of Cyt Bo3 and NmqNOR. (A) shows the overall dimeric 
structure of NmqNOR (this study) in cyan. qNOR only have single subunit for each of 
monomer. (B) shows the overall crystal structure of Cyt bo3 coloured by the subunit. Subunit I 
coloured in green, subunit II coloured in cyan, and subunit III and IV were coloured in pink 












4.2 MATERIALS AND METHODS 
 
4.2.1 Purification of recombinant NmqNOR 
 
Wild type and mutants of NmqNOR were expressed in C43 (DE3) E.coli strain 
(Lucigen) and were cultured in 2xYT medium with addition of 0.5 mM b-d-1-
thiogalactopyranoside (IPTG) to induce overexpression. The protein was purified using 
detergent dodecyl-b-maltoside (DDM, Dojindo) and detergent was exchange in final size 
exclusion chromatography (SEC) with n-decyl-b-d-thiomaltoside (DTM, Anatrace) (Gonska 
et al., 2018; Jamali et al., 2020). 
 
4.2.2 Site directed mutagenesis 
 
Site directed mutagenesis was done by using Q5 site directed mutagenesis kit (New 
England Biolabs) by using the primers shown in Table 4.1 . Sequence verification of the 
mutagenesis PCR product was done at RIKEN Wako (Japan). Mutants were overexpressed in 
C43 (DE3) E. coli strain, following the methods for that of wildtype NmqNOR. 
 
4.2.3 UV-visible spectra measurement 
 
UV-visible spectra of wildtype and mutant NmqNOR were measured using a Jasco-
V630 Spectrometer. All measurements were carried out by using a quartz cuvette and 
wavescans of samples were performed across 250-700 nm with 1 nm step. Preparation of 
reduced qNOR was performed in an airtight quartz cuvette with a rubber seal, by the addition 
of 500 mM dithionite (Sigma Aldrich).  
 
4.2.4 Measurement of NO consumption by NmqNOR  
 
NO reduction activity was determined using an NO electrode (World Precision 
Instrument (WPI) inc.) at room temperature (Figure 4.2). The buffer contained, 50 mM 
HEPES-Na pH 8.0, 150 mM NaCl and 0.05% (v/v) DDM, which was made anaerobic by 
oxidation of 1 M glucose by 10 µL/mL glucose oxidase with 10 µL/mL catalase inside the final 
buffer solution. The sample was then incubated (with gentle stirring) for about 5 minutes to 
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ensure all the oxygen was consumed via the glucose oxidation process. NO buffer was made 
in a glass vial by replacing the air inside with N2 gas and then bubbling NO gas into 5 ml 50 
mM HEPES pH 8.0, 150 mM NaCl and 0.05%(w/v) DTM buffer for 20 minutes, to achieve a 
saturated NO solution (~ 2mM). Serial concentrations of electron donor were used, which 
ranged from 1.25 µM to 10 µM (final concentration in assay) (Fig. 4.4) for each respective 
electron donor (Fig. 4.3) (PMS, MD, UQ1,Sigma). Each of these were paired with DTT as a 
redox mediator; DTT final concentration in buffer used was at 10 µM  for each of reaction. For 
kinetic measurements with inhibitors (Fig. 4.3 D and Fig. 4.3 E), NO reduction assays were 
repeated with same conditions as above with the addition of  inhibitor concentrations ranging 
from 0.5 mM to 5 mM into the assay solution. NO reduction activity was analysed by using 



















Figure 4.2. NO reduction set up. Illustration of experimental set up for the NO measurement 
of NmqNOR. Series of buffer used as mention in the method above in order to make the 





















Figure 4.3. Chemical compound of electron donor and inhibitor used in the kinetic 
measurement. (A) shows the chemical compound of menadiol (MD), (B) shows chemical 
compound ubiquinol-1 (UQ1), and C shows chemical structure of Phenazine Methosulfate 
(PMS), in which all these three compound were the electron donor used in this experiment. D 
and E shows the inhibitor in which D is the structure of 2-Heptyl-4-hydroxyquinoline n-oxide 




















































4.3 RESULTS AND DISCUSSION 
 
4.3.1 NO Reduction by detergent solubilized NmqNOR with Three Electron Donors  
 
We followed the NO consumption kinetics of NmqNOR by using three different 
electron donors; ubiquinol-1 (UQ1), menadiol (MD) and Phenazine Methosulfate (PMS). PMS 
is a non-specific electron donor, since it does not bind to the Q-site of the enzyme but is able 
to donate electrons non-specifically. Indeed, our previous study on cytochrome c dependent 
NOR (cNOR) from Pseudomonas aeruginosa, which does not utilise quinol as an electron 
donor, showed that PMS could donate electrons directly to the catalytic site, in the absence of 
a quinol binding site (T. Hino et al., 2010; Schurig-Briccio et al., 2013). Thus, it means that 
PMS can donate the electron to active site without binding towards the Q-site in NmqNOR and 
can be used as the positive control. 
 
 The kcat and km values obtained using the Michaelis-Menten formula are compiled in 
Table 4.2. MD provided  higher kcat and lower km values (45 s-1 and 7 µM), compared with the 
corresponding values of UQ1 (37 s-1 and 15 µM) and PMS (36 s-1 and 17 µM), showing that 
MD is a more efficient electron donor for NmqNOR, compared to UQ1 and PMS on the basis 
of the smaller Km value, indicative of higher substrate affinity. 
 
There is no report for a native quinol analogue working as the electron donor in the NO 
reduction in N. meningitidis. By contrast, UQ10 and UQ8 analogues have been identified as the 
native electron donor in mitochondria, and have been extensively studied with  Cyt bo3 and 
complex 1 (NADH :Ubiquinone oxidoreductase) (Welter et al., 1994; Yap et al., 2010; Fedor 
et al., 2017; Melin et al., 2018). We chose UQ1 and MD as electron donors in this experiment, 
because our measurements were done with NmqNOR in detergent, similarly done with 
Cytbo3(Yap et al., 2010; Szundi et al., 2014; Choi, Lin, et al., 2017). Even though the native 
electron donor for Cytbo3 is UQ8, the experimental condition with UQ1 showed this electron 
donor remained tightly bound to the enzyme (Yap et al., 2010). UQ1 (with the shortest 
isopropyl tail) is soluble in ethanol and can be added into the aqueous solution of the detergent 
solubilized enzyme. The isopropyl tail from quinol was proposed to fit and guide the quinol 
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binding within the quinol pocket for further proton transfer towards the proton entry site. This 
mechanism was proposed in bovine complex I quinol binding site, in which the dependence of 
Km and Vmax on quinol isoprenoid chain length was investigated. Increases in quinol isoprenoid 
chain length led to higher kcat values and lower Km values (Fedor et al., 2017). This difference 
in dissociation of quinol analogues might be one of the reasons why the affinity of UQ1 is lower 






Figure 4.4. Single Set Measurement of NO reduction by NmqNOR. Figure shows the series 
of NO reduction measurement by using the NO electrode. Seven different concentrations of 

















4.3.2 Quinol Binding Site Prediction on NmqNOR 
 
To identify the binding site of these electron donors in NmqNOR, we measured the NO 
consumption kinetics, for some mutants, in which residues of a possible quinol binding site 
(Q-site) were substituted. For design of the mutation sites, we referred to the crystallographic 
structure of the GsqNOR-inhibitor HQNO complex, as well as the recent determined cryo-EM 
structure of NmqNOR.  
 
His328, Glu332 and Asp746 were identified as the residues of the Q-site in GsqNOR 
(by virtue of HQNO binding as a quinol analogue), with the corresponding residues in 
NmqNOR His303, Glu307 and Asp728. Indeed, the structure of NmqNOR by cryo-EM 
(PDB:6L3H) (Fig. 4.5), indicated that the Q-site structure is apparently conserved, compared 
with the GsqNOR and other qNORs. Cavity search on Pymol shows that the presence of cavity 
corresponds to the predicted quinol binding site between TM III and TM XIV of NmqNOR 
(Fig. 4.6 and Fig. 4.7). This cavity has the opening near the periplasmic associate with the 
Thr751 and His 303, and end towards Asp728. Superimposed structure between HQNO-bound 
GsqNOR (purple) and NmqNOR (Cyan) in the quinol binding site shows the similarities in 
these three amino acid residues that are predicted to be associated with the quinol binding in 
the qNOR. HQNO head group in GsqNOR model binds towards the end of the cavity and two 
oxygen subgroups from HQNO bind towards the Asp and His group in model of GsqNOR. 
Binding position of HQNO shows that the Asp residue in both qNORs are meant to transfer 
the electron from the donor towards the active site, while His residue is meant to transfer the 
proton from the donor towards the Glu residue. These three residue seem to have similar 


















Figure 4.5. Sequence alignment among qNORs from several species by using Clustal W. 
Three main residues predicted to be the quinol pocket are conserved amongst qNOR species, 
except the Glutamate reside, which is replaced by an Aspartate residue in the P. marina species. 
 
 
Figure 4.6. Overall structure of NmqNOR. Figure shows the overall structure of monomeric 
structure of NmqNOR by Cryo-EM PDB:6L3H). the quinol pocket was predicted to be in 
between TM III and TM XIV. This was based on the conserved region of quinol pocket 




















Figure 4.7. HQNO prediction binding site. Figure shows superimposed structure of 
NmqNOR (Cyan) with the inhibitor bound(HQNO in stick) of GsqNOR(Purple). The cavity 
search on NmqNOR model was prepared by cavity search function in the Pymol software.  
 
 
We replaced the aforementioned residues with Alanine, and obtained three Q-site 
variants of NmqNOR, i.e., H303A, E307A and D728A. In Table 4.2, the NO reduction 
activities with three different types of electron donors are compared between the WT enzyme 
and three variants. As expected, when using PMS, the activities of the three variants were not 
largely diminished, with 61-85% activity compared to WT. Therefore, it was concluded that 
upon the present mutations of NmqNOR, the structure still retains its binuclear centre (heme b3 
and FeB). Thus, the functional changes could be interpreted in terms of the structural change 
around its Q-site. In contrast, when using UQ1 or MD as an electron donor, the NO reduction 
activities of H303A and D728A were almost diminshed (less than 1% of WT). The significant 
loss of NO reduction capabilities indicated that the quinol binding site of NmqNOR was 
disrupted upon the mutations. With reference to the structure of GsqNOR in complex with the 
inhibitor HQNO, we predicted that OH and N-oxide group from the quinol ring would form 
hydrogen bonds with Asp728 and His303 (Fig. 4.7), respectively, in NmqNOR, and the quinol 
headgroup would be sandwiched between these two side chains. The predicted interaction and 









On the other hand, Glu307 is expected not to directly interact with quinol and be located 
towards the extracellular side of the enzyme(Matsumoto et al., 2012).  The role of the residue 
in qNOR was proposed to be involved in the proton transfer from quinol to the extracellular 
side, upon oxidation of quinol. This is probably a reason for the decreased but slightly higher 
NO reduction activity of E307A mutant (~ 9 % of WT), compared with other two mutants, 
H303A and D728A. 
 
 









DTT/UQ1 37 ± 2 100 15 
DTT/MD 45 ±3 120 7 
DTT/PMS 36 ± 2 99 17 
E307A 
DTT/ UQ1 3.3 ± 0.4 9.1 40 
DTT/MD 14  ± 1 39 23 
DTT/PMS 31  ± 2 85  
D728A 
DTT/ UQ1 0.15 ± 0.02 0.4  
DTT/MD 0.05 ± 0.01 0.14  
DTT/PMS 24 ± 2 66  
H303A 
DTT/ UQ1 0.01 ±0.04 0.27  
DTT/MD 0.5 ± 0.1 1.4  
DTT/PMS 22 ± 1 61  
Table 4.2 shows the results of Kcat and Km measurement based on three type electron donors. 
MD shows has the lowest Km and highest Kcat value. UQ1H2  has Km of 15 µM  and PMS has 









4.3.3 Electron Transfer inhibition of NmqNOR by quinol-based inhibitors 
 
To examine the inhibitory effect of HQNO and BQ on the NO consumption of 
NmqNOR, NO reduction assays were carried out with the three aforementioned electron donors 
in the presence of HQNO and BQ. When UQ1 and MD were used as electron donors, HQNO 
and BQ showed inhibitory effects. The Michaelis-Menten’s fitting curves showed that HQNO 
exhibited non-competitive inhibition, while BQ was likely a competitive inhibitor (Figs 4.8, 
Fig. 4.9, Fig. 4.10, and Fig. 4.11).  Table 4.3 summarizes the respective inhibition pattern and 
inhibition constants (ki). The ki values for HQNO were 2.2 µM (UQ1) and 2.4 µM (MD), which 
were much lower than ki of BQ (8 µM (UQ1) and 9 µM (MD), respectively. In the three mutants 
we prepared, only E307A retains NO reduction activity, thus enabling us to conduct a kinetic 
study with inhibitors. The inhibition pattern of both HQNO and BQ were non-competitive 
(Fig.4.12, Fig. 4.13, Fig. 4.14, Fig. 4.15), which is not consistent with the WT enzyme with 
respect to the BQ mode of inhibition. The different inhibition pattern in E307A, compared with 
WT, was due to the important role of this residue in quinol binding. This can be explained 
based on structural analysis of both NmqNOR and GsqNOR structures, where the Glutamate 
residue is hydrogen-bonded to the histidine residue (Fig. 4.7). Thus, this site-direct mutagenesis 
affects the structure of quinol binding site and might cause the inhibitor to bind to this enzyme 
independently with the UQ1. 
 
These inhibitors were selected based on the previous study of quinol binding in Cyt bo3 
(Sato-Watanabe et al., 1994; Ohnishi, Salerno and Ohnishi, 2010; Yap et al., 2010). Earlier 
hypothesis suggested that the quinol binding site of NmqNOR would not vastly differ to that 
of Cytbo3. Steady state kinetics results in Table 4.3 show different inhibition pattern between 
HQNO and BQ in NmqNOR. One possible reason to explain this result is due to the different 
alkyl-tail length between both inhibitors, which may alter their ability to bind towards the Q-
site of qNOR. HQNO contains 7 carbon alkyl chain while BQ lacks an alkyl tail, thus BQ 
structure is similar with that of UQ1. Thus, it is predicted that BQ competes for the same 
binding location as UQ1, while the extended carbon chain present in HQNO (Figure 4.7) might 
cause it to bind slightly differently to UQ1 on the Q-site, whilst still involving the same residue. 
HQNQ is visible in the GsqNOR-HQNO structure electron density map, where its carbon chain 
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likely moves to the periphery of the Q-site, stabilized by conserved hydrophobic residues (e.g. 
Phe336 in GsqNOR)(Matsumoto et al., 2012).  
 
 
Table 4.3. Inhibition patter of HQNO and BQ in WT and mutant 






HQNO Non-competitive  2.2 
BQ Competitive  8 
DTT/MD 
HQNO Non-Competitive  2.4 





HQNO Non-Competitive  11 
BQ Non-Competitive  12 
DTT/MD 
HQNO Non-Competitive  24 








Figure 4.8. Non-competitive inhibition pattern of WT with present on HQNO by using 
menadione as the electron donor. 
 
 
Figure 4.9. Competitive inhibition pattern of WT with present on BQ by using menadione 
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Figure 4.12. inhibition pattern of E307A mutants with present on HQNO by using 




Figure 4.13. inhibition pattern of E307A mutants with present on BQ by using menadione 
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Figure 4.16. Quinol binding location in the CytBo3. CytBo3 consist of 4 subunits in which 
quinol binding location was located in the subunit I (rectangular dash). (B) Enlargement of the 
quinol binding pocket in the CytBo3 shows amino acid residue (stick) that associate with the 
electron transfer to the active site by quinol analogue. 
 
 
4.3.4 Comparison of Quinol Binding and Electron Transfer between qNOR and Cytbo3 
 
Based on the results, it can be concluded that both the structure and location of quinol 
binding site of qNOR and Cyt bo3 are different. The quinol binding site consists of two helices 
both in qNOR and Cytbo3, however position of the helices are different between these two 
enzymes. In Cytbo3, the pocket was located in subunit I between TM II and TM IV (Fig. 4.16 
(A) and (B)). In contrast, the binding site in NmqNOR is in between TM III and TM XIV (Fig. 
4.6 and Fig. 4.7). In Cyt bo3 ,there is no inhibitor- or quinol analogue-bound structure yet 
published, the Q-site was determined based on intensive site direct mutagenesis experiments 
on the predicted conserved region (R71, D75, H98, and Q101) of Q-site (Abramson et al., 
2000; Yap et al., 2010; Fedor et al., 2017; Melin et al., 2018). The finding of Cyt bo3 showed 
that its only have one quinol binding site (Choi, Lin, et al., 2017; Fedor et al., 2017), which 
would be similar to the quinol binding site in qNOR. This was based on the presence of HQNO 
from the structure of GsqNOR, where only one HQNO binding site was observed in this 


















 The aim of this chapter is to understand the property of the electron transfer from 
electron donor to NmqNOR by analysing the steady state kinetics on the NO reduction activity. 
The site-directed mutagenesis on the predicted quinol pocket (His 303 and Asp 728) showed 
significant loss in the NO reduction activity of NmqNOR with quinol, but not with non-specific 
electron donor, PMS, which indicates these residues were crucial for quinol recognition in 
NmqNOR. Inhibition study on NmqNOR with the quinol analogues showed that HQNO non-
competitively inhibited while BQ competitively inhibited the electron donor. Furthermore, the 
alteration of Glu307, located around the quinol binding pocket, caused the inhibition pattern of 
BQ from competitive (in wild type) to non-competitive inhibition. These results imply that the 
shape of the quinol binding site could control the specific recognition of the quinol moiety. In 
order to get more insights into the electron transfer and quinol oxidation in NmqNOR, an 




























The high resolution cryo-EM structure of native NmqNOR was successfully elucidated, 
as detailed in Chapter 3. In the higher resolution structure, a water channel and putative proton 
pathway of NmqNOR can be assigned. The X-ray structure with inhibitory zinc, revealed that 
the entry and exit residues responsible for the proton transfer was successfully identified as 
shown in chapter 2. In Chapter 4, the steady state kinetics in the presence of inhibitors and site 
directed mutagenesis on the quinol pocket of NmqNOR proved that three residues responsible 
for quinol binding were identified. It is crucial for us to obtain the structures of both inhibitor 
(BQ, and HQNO) bound NmqNOR for a better understanding of quinol oxidation in the quinol 
pocket of NmqNOR. Inhibitor- bound structures will also provide better insight into the 
inhibition pattern; HQNO non-competitively competes with the quinol analog whereas BQ 
competitively inhibited the quinol binding. With access to cryo-EM facilities in RIKEN 
SPring-8 centre, which is equipped with 200 kV Glacios Cryo Transmission Electron 
Microscope (Thermo Fisher), it provided an opportunity for elucidation of NmqNOR with 
inhibitor complexes. To test the feasibility of structural analysis of NmqNOR using 200 kV 
instrument, an initial data set of wild type NmqNOR was collected overnight (~ 16 h) and the 
resolution obtained was 4.1 Å from ~ 10,000 particles. As such, a grid of NmqNOR with 
inhibitor of HQNO was made and subsequently imaged for ~ 48 h. The result from data 
processing showed a final resolution obtained was 3.1 Å, which is similar resolution with the 
data collection done in University of Leeds. HQNO density was visible in the quinol pocket 
and several residues in the quinol pocket also have stronger density compared with the wild 
type. This might be due to HQNO stabilizing the region where several amino acids near a 





5.2 MATERIALS AND METHODS 
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5.2.1 NmqNOR-HQNO purification 
 
NmqNOR fused with Bril were used throughout this experiment as it proven give higher 
resolution during cryo-EM measurement as discussed in chapter 3. Purification step was 
similar as in chapter 2 and 3, and during the final step glycerol was excluded during the gel 
filtration step. 10 mg/ml of NmqNOR sample were incubated with 1 mM HQNO for 15 minutes 
before diluted for grid preparation.  
 
5.2.2 Cryo-EM Sample Vitrification and Data Acquisition 
 
For cryo-EM grid preparation, 3 µL of NmqNOR-HQNO at 4 mg/mL was applied to 
glow discharged (Pelco) R1.2/R1.3 Cu Holey carbon grids (Quantifoil). Grids were then 
blotted using a blot force of 6, for 6 seconds and then plunge frozen into liquid ethane using a 
Vitrobot Mark IV (Thermo Fisher Scientific), maintained at 4oC with ~ 98 % humidity. 
Screening and data collection took place using a Glacios Cryo-TEM (Thermo Fisher Scientific) 
at the RIKEN SPring8 Center (Japan) operating at an acceleration voltage of 200 kV, equipped 
with a K2 Summit Detector (Gatan) in counting mode. Imaging was performed at a nominal 
magnification of 130,000x, leading to a calibrated pixel size of 1.18 Å/pixel. A total of 4,816 
movies were recorded. The dose rate was 1.23 e-/Å2/s-1 recorded over 8 seconds, captured in 
40 frames, resulting in a total dose of 49.2 e-/Å2, with a defocus range from – 1 to -3.5 µm. 
Data collection was performed using EPU software (Thermo Fisher Scientific). 
 
5.2.3 Image Processing of cryo-EM movies 
 
Image processing was initially performed in RELION 3.0.8 (Zivanov et al., 2018) and 
then  RELION 3.1(Zivanov, Nakane and Scheres, 2020) (updated version) for high resolution 
refinement procedures. Movies were motion corrected (with dose-weighting) using RELION 
3.0.8 own implementation of MOTIONCORR. CTF estimation was performed using 
CTFFIND 4.1.10 (Rohou and Grigorieff, 2015). The image of observed particles is shown in 
Fig. 5.1. An initial 2126 particles were picked using Laplacian of Gaussian (LoG) picking 
procedure to generate initial 2D templates that we used for auto-picking of all micrographs. 
After auto-picking, 2,440,689 particles were extracted (200-pixel box size). Particles were 
subjected to 2D classification (8 rounds with 10 Å expectation step limit) which generated 
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classes with a variety of views and elements of secondary structure (Fig. 5.2). An initial model 
was generated (C1 symmetry) which was then used during 3D classification (K= 4, 10 Å 
expectation step limit) upon filtering to 50 Å. The best classes from each round of classification 
served as references for the next round. After 8 rounds of 3D classification with the previous 
settings, two rounds (K= 3, no expectation step resolution limit) of classification left the best 
class composed of 70,483 particles. 3D auto-refinement of this class lead to a resolution of 4.3 
Å in C1 symmetry, with map sharpening yielding a 4.0 Å reconstruction. Refinement in C2 
symmetry led to a resolution of 4.0 Å, with map sharpening using a tight solvent mask 
(excluding the detergent belt and BRIL molecules, with 6 pixels cosine edge added) improving 
the resolution to 3.8 Å, up to this step, all image processing was done in RELION 3.0.8.  
 
These particles were then subjected to CTF refinement in RELION 3.1, with CTF 
higher order beam tilt, anisotropic magnification, CTF parameter fitting and per particle 
defocus values re-estimated(Zivanov, Nakane and Scheres, 2020). Refinement and map 
sharpening led to a map of 3.5 Å resolution, before Bayesian particle polishing was performed 
using all movie frames and parameters previously determined from a training step which used 
4,000 particles. The ‘shiny’ particles were auto refined to 3.8 Å, with map sharpening using a 
tight mask leading to a resolution of 3.27 Å. Particle subtraction mode was used in order to 
remove unwanted micelle density, in which lead to the high signal on the core part of the map. 
This map was again autorefined to 3.63 Å and final resolution after map sharpening was 3.10 
Å. All resolution estimates were calculated using the ‘gold standard’ Fourier Shell Correlation 
(FSC)= 0.143 (Scheres and Chen, 2012). ResMap v.1.95 (Kucukelbir, Sigworth and Tagare, 
2014) was used to assess slice through local resolution estimates, using the default finest and 
coarsest resolution limits (2x and 4x pixel size, respectively). Map volumes and masks were 














*Resolution determined by RELION 3.0, † Mean B-factors determined by Phenix 
Parameters NmqNOR-HQNO  
Microscope and Detector Glacios with K2 Summit 
(Gatan) 
Location RIKEN SPring8 Center,  
Japan 
Voltage (kV) 200 
Magnification 130,000x 
Pixel size (Å) 1.18 
Defocus range (µm) -1.5 to -3.5 
Total dose (e-/A2) 49.2 
No. of frames 40 
Exposure time per frame 0.3 
Dose per frame (e-/Å2) 1.23 
No. of micrographs 4,815 
Total autopicked particles  
Particles in final 3D refinement  
Symmetry Imposed C2 
Map Sharpening B-factor (Å2) - 80 
Map Resolution* (Å) 
(FSC threshold= 0.143) 
3.10 
Refinement 
Starting model for structure 
refinement 
NmqNOR (chapter 3)(6L3H) 
CC (mask) 0.82 
CC (main chain) 0.88 
CC (side chain) 0.86 
CC (ligands) 0.81 
Non-hydrogen atoms 11,966 






Bond lengths (Å) 0.007 
Bond angles (o) 0.748 
Clash score 7.35 
MolProbity score 1.92 
Poor rotamers (%) 0.16 
Ramachandran Plot 
Favoured (%) 91.06 
Allowed (%) 8.94 
Outliers (%) 0 
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Figure 5.1. NmqNOR-HQNO complex particle on the grid. Figure shows the spread of 
particle on the grid prior to the particle picking. The particles have almost similar diameters as 
previously observed in wild type measurement (Chapter 3). There is some ethane 
contamination on the grid as observed above, however it not giving much effect toward the 














Figure 5.2. 2-Dimensional classification of NmqNOR-HQNO complex. Ten class was 
generated in the final 2D classification after particle polishing step. Each of classes shows 




Figure 5.3. Overall Structure of NmqNOR-HQNO complex.  NmqNOR-HQNO dimeric 
model after structure refinement and model building docked into the sharpened cryo-EM 
derived map (grey outline), chains A coloured in dim grey, chain B coloured in cyan and 












5.3 RESULTS AND DISCUSSION 
 
5.3.1 HQNO binding position in NmqNOR revealed by cryo-EM 
 
Results of inhibition in chapter 4 showed that HQNO non-competitively inhibited the 
quinol binding to NmqNOR. For better understanding on how HQNO interacts with the 
NmqNOR, sample was incubated with HQNO prior to grid preparation. Final EM map obtained 
showed a clear density in the pocket where the native quinol is predicted to bind for catalytic 
NO reduction. Figure 5.4 shows the map comparison between WT (chapter 3) and HQNO 
bound complex. In the WT map, at same contour level, there is no density present in the quinol 
pocket, which allowed HQNO to be modelled at the density observed around the possible 
quinol binding site. In the HQNO-bound model, HQNO headgroup forms a hydrogen bond 
with the Asp 728 and Tyr 312, where N-oxide in HQNO binds to the Tyr 312 and the carboxyl 
carbon group binds towards Asp 728 (Fig.5.5 (B)). Tyr 312 was located in a flexible loop (Fig. 
5.5 (A)) near the periplasmic region, which had poor density in the WT EM map (Fig 5.6 (A)). 
Binding of HQNO in the quinol pocket might stabilize the flexible loop region in NmqNOR 
and hence allowed Tyr 312 to be built. A few hydrophobic residues are also responsible for 
HQNO binding as the head group was interacted by two uncharged residues which are Trp 722 
and Thr 755, while the tail group seems to be stabilized by Leu 296 and Phe 311 through 




























Figure 5.4. Comparison of density in proposed Q-site varies from WT and HQNO 
complex of NmqNOR. A) Density (grey map) of quinol pocket in the WT NmqNOR, B) The 
density (yellow map) of HQNO complex of NmqNOR at the same contour level in UCSF 
Chimera software(Pettersen et al., 2004). WT model were used the cartoon (pink colour) in 
both maps. A clear difference near the quinol pocket shows the presence of head and tail group 











































Figure 5.5. Structure of NmqNOR-HQNO complex. (A) Overall structure of NmqNOR-
HQNO complex obtained. Dotted box shows the position for the quinol pocket in NmqNOR, 
and Tyr 312 was located the flexible loop region where the density in WT was poor due to the 
flexibility region. (B) Quinol pocket of NmqNOR where the present of HQNO density (red 
mesh) (map contoured at 3s)  and the charged amino acid residue of Asp 728, Tyr 312,His 303 
and Glu 307 (map contoured at 6 s), which  are responsible for the oxidation of quinol and 
electron transfer to active site of NmqNOR. (C) Shows the hydrophobic/uncharged amino acid 
residues of Thr 725, Leu 296, Phe 311 and Trp 722 (map contoured at 6 s) that involve in the 



































Figure 5.6. Structure comparison between WT and HQNO complex of NmqNOR. (A) 
Structure of charge amino acid residue between WT (Green colour) and HQNO complex (Cyan 
colour). The obvious confirmation charge between two structure was we enable to build Tyr 
312 in HQNO complex as in the WT the density of Tyr 312 was too poor to be build. (B) 
Structure of uncharged residue that ligated toward the head and tail group of HQNO. Phe 311 
in WT shift toward the downward position as it means to accommodate for the tail group of 
HQNO. 
 
5.3.2 Structural difference of Q-site between NmqNOR and GsqNOR 
 
By comparing the current structure of NmqNOR-HQNO complex with that of 
GsqNOR, the binding position of HQNO is different between these qNORs. In GsqNOR, 
oxygen subgroup in HQNO were ligated to Asp and His 328 residues, and the position of Tyr 
312 in NmqNOR was replaced by Phe 337 (Fig. 5.7 and Fig. 5.8). This hydrophobic residue 
might also affect the binding position of HQNO in GsqNOR compared with HQNO binding 
position in NmqNOR. Headgroup of HQNO proton released upon the quinol oxidation in 
NmqNOR and GsqNOR might have different pathway based on this structure, in GsqNOR, 
proton from quinol oxidation were associated His 328 to Glu 332, while in NmqNOR direct 
interaction of Tyr 312 with oxygen in HQNO shows that Tyr 312 might involve in the 




















Kinetic data in chapter 4 shows HQNO non-competitively inhibits and BQ 
competitively inhibits the quinol analogue in NmqNOR. We predict this happens due to the 
difference in the chemical structure between HQNO with quinol analogue and BQ. In HQNO, 
headgroup that bind into the Q-site contain one N-oxide group and one carboxyl carbon group, 
while in chemical compound in BQ contain both carboxyl carbon group which is similar with 
the property of the head group in the quinol analogue (Chapter 4 (Fig. 4.3)). Thus, we predicted 
the functional group in the head group of electron donor and inhibitor play a vital role whilst 
bound into the Q-site of NmqNOR. However, native quinol binding of Q1 or competitive 
inhibitor structure of BQ with NmqNOR are needed in order to fully understand the differences 
between binding mode of HQNO with BQ or Q1. 
 
 
Figure 5.7. HQNO bound into the quinol pocket of NmqNOR and GsqNOR. Differing 
binding modes of HQNO for NmqNOR (cyan) and GsqNOR (blue). Head group HQNO in 
























Figure 5.8. Sequence comparison between charge residue in the q-site. Figure shows that 
the sequence comparison and shows that the Tyr 312 in NmqNOR was replaced by 





 Through the structural analysis of NmqNOR described in this chapter, a method for 
obtaining a high-resolution structure using cryo-EM facility in RIKEN, SPring-8 center, was 
established. Current structure of NmqNOR-HQNO complex showed the first inhibitor complex 
structure of an active qNOR. This will provide more insight into how inhibitor binds to 
NmqNOR and inhibits the activity of the enzyme. The binding of the quinol analogue was 
found to induce structural changes around the binding site, and Tyr-312 possibly serves as a 
key residue for the recognition of the quinol moiety. To understand more about the inhibitory 
action of quinol analogue and mechanism for the electron transfer from quinol, it is highly 
desirable to solve the structure of NmqNOR with different types of inhibitor such as BQ. In 
addition, further site-directed mutagenesis studies based on the recent finding of the possible 













General Conclusion and Future Improvement 
 
6.1 GENERAL CONCLUSION 
 
Main objective in this thesis is to elucidate the structural and functional properties of 
NmqNOR, which is responsible for the elimination of NO produced by hosts’ immune system 
for human pathogen, Neisseria meningitiis. By using Cryo-EM, the structure of NmqNOR was 
solved in native form at a resolution of 3.06 Å (Chapter 3), while the structure determined from 
X-ray crystallography was at a 3.15 Å resolution (Chapter 2). The X-ray crystallography 
structure showed the presence of zinc atoms near the entrance and end of the hydrophilic cavity 
from cytoplasmic to the catalytic centre of protein. Zinc was found to work as the inhibitor for 
proton transfer in NmqNOR. This finding answers the question on how the catalytic proton is 
supplied towards the active site of NmqNOR. The resolution of the cryo-EM structure was high 
enough to determine the native structure of active NmqNOR and understand our main focus of 
active site configuration in qNOR. FeB in the active NmqNOR was ligated by 4 ligands, three 
His and one Glu, while the previous study on qNOR (AxqNOR) and the current crystal structure 
of NmqNOR shows the FeB was ligated by 3 ligands, only three His. In the crystal structure, 
Glu 494, which serves as a ligand of FeB in the cryo-EM structure, was flipped to coordinate 
to Zn2. It can, therefore, be concluded that Glu 494 was flexible and responsible for the proton 
movement near the active site in the water channel of NmqNOR during NO reduction reaction. 
Structure-based mutagenesis and functional assays provided invaluable information on the 
electron transfer (Chapter 4). Previously, our group has successfully elucidated structure of 
GsqNOR with the quinol analogue. Site directed mutagenesis on the conserved residues around 
possible quinol analogue binding site in NmqNOR showed that these 3 residues, Asp 748, His 
303 and Glu 307, were important as NmqNOR showed significant loss of the activity upon the 
substitutions of these residues. Furthermore, insights into the inhibition properties of quinol 
analogues were successfully obtained. Two inhibitors, HQNO and BQ, showed non-
competitive and competitive inhibition with electron donor, respectively. The NmqNOR-
HQNO complex was also successfully determined at a 3.10 Å resolution by cryo-EM (Chapter 
5). In this structure, HQNO is proven to bind towards the Q-site where HQNO binds in the 
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previously obtained GsqNOR structure. The structure suggested that, in addition to Asp 748, 
His 303, and Glu 307, Tyr 312 could play a vital role in the recognition of quinol oxidation as 
Tyr 312 in HQNO complex showed direct interaction with the N-oxide in the HQNO. This 
new information would provide a clue to understand the inhibition properties of quinol 




6.2 FUTURE IMPROVEMENT 
 
 In future, several experiments are suggested to improve this study on NmqNOR. The 
first step is to reconstitute NmqNOR into nanodisc. Currently, all measurements including 
cryo-EM and kinetic study of NmqNOR has been done in detergent. If we were able to 
reconstitute it into nanodisc, activity measurements between NmqNOR in nanodisc and 
NmqNOR in detergent NmqNOR would need to be carried out in order to understand the 
effectiveness of the nanodisc to qNOR. With NmqNOR in nanodisc, the resolution by Cryo-
EM would be expected to be improved as the nanodisc helps to stabilize and increase the size 
of the protein. Measuring the steady state kinetics of NmqNOR with a longer tail of quinol 
analog such as UQ8H or UQ10H would also be able to be examined, as a hydropboic long tail 
quinol analog cannot be used in standard NO reduction measurement whilst in detergent. A 
third suggestion is to obtain the Cryo-EM structure of NmqNOR with the presence of BQ and 
Q1. Currently we only have the non-competitively inhibition mode of HQNO binding to 
NmqNOR. Comparison between non-competitive, competitive and electron donor binding 
substrate will provide novel findings for the enzyme that utilises quinol analog as the electron 
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